Impaired	O
fetal	B-cell_type
thymocyte	I-cell_type
development	O
after	O
efficient	O
adenovirus-mediated	O
inhibition	O
of	O
NF-kappa	B-protein
B	I-protein
activation	O
.	O

We	O
introduce	O
a	O
new	O
experimental	O
system	O
combining	O
adenovirus-mediated	O
gene	O
transfer	O
and	O
fetal	O
thymic	O
organ	O
culture	O
(	O
FTOC	O
)	O
.	O

This	O
system	O
allowed	O
us	O
to	O
efficiently	O
express	O
in	O
developing	O
thymocytes	O
a	O
mutant	O
form	O
of	O
the	O
NF-kappa	B-protein
B	I-protein
inhibitor	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
(	O
mut-I	B-protein
kappa	I-protein
B	I-protein
)	O
and	O
to	O
study	O
the	O
maturation	O
defects	O
occurring	O
when	O
NF-kappa	B-protein
B	I-protein
activation	O
is	O
inhibited	O
during	O
fetal	O
development	O
.	O

Fetal	B-cell_type
thymocytes	I-cell_type
infected	O
with	O
adenovirus	O
containing	O
mut-I	B-protein
kappa	I-protein
B	I-protein
were	O
found	O
to	O
develop	O
normally	O
until	O
the	O
CD44	B-protein
-CD25+	O
,	O
CD4	B-protein
-	O
CD8	B-protein
-	O
double-negative	O
stage	O
,	O
while	O
production	O
of	O
more	O
mature	O
double-positive	O
and	O
single-positive	O
populations	O
was	O
strongly	O
decreased	O
.	O

Proliferation	O
,	O
as	O
measured	O
by	O
the	O
percentage	O
of	O
cells	O
in	O
cycle	O
appeared	O
normal	O
,	O
as	O
did	O
rearrangement	O
and	O
expression	O
of	O
the	O
TCR	B-protein
beta-chain	I-protein
.	O

However	O
,	O
apoptosis	O
was	O
much	O
higher	O
in	O
FTOC	O
infected	O
with	O
adenovirus	O
containing	O
mut-I	B-protein
kappa	I-protein
B	I-protein
than	O
in	O
FTOC	O
infected	O
with	O
a	O
control	O
virus	O
.	O

Taken	O
together	O
,	O
these	O
results	O
suggest	O
that	O
NF-kappa	B-protein
B	I-protein
plays	O
a	O
crucial	O
role	O
in	O
ensuring	O
the	O
differentiation	O
and	O
survival	O
of	O
thymocytes	B-cell_type
in	O
the	O
early	O
stages	O
of	O
their	O
development	O
.	O

K	NULL
Boldly	NULL
GolnVivo	NULL
``	NULL
``	NULL
BioLegend®	NULL
Le	NULL
meJournal	NULL
o	NULL
Impaired	NULL
Fetal	NULL
Thymocyte	NULL
Development	NULL
After	NULL
P	NULL
'	NULL
Imnmunolo	NULL
gy	NULL
Efficient	NULL
Adenovirus-Mediated	NULL
Inhibition	NULL
of	NULL
NF-KB	NULL
Activation	NULL
Talitha	NULL
R.	NULL
Bakker	NULL
,	NULL
Toufic	NULL
Renno	NULL
and	NULL
C.	NULL
Victor	NULL
Jongeneel	NULL
J	NULL
Immunol	NULL
1999	NULL
;	NULL
162	NULL
;	NULL
:3456-3462	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/6/3456	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
47	NULL
articles	NULL
,	NULL
18	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/6/3456.full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
Impaired	NULL
Fetal	NULL
Thymocyte	NULL
Development	NULL
After	NULL
Efficient	NULL
Adenovirus-Mediated	NULL
Inhibition	NULL
of	NULL
NF-rB	NULL
Activation	NULL
Talitha	NULL
R.	NULL
Bakker	NULL
,	NULL
*	NULL
``	NULL
Toufic	NULL
Renno	NULL
,	NULL
'*	NULL
and	NULL
C.	NULL
Victor	NULL
Jongeneel	NULL
``	NULL
*	NULL
We	NULL
introduce	NULL
a	NULL
new	NULL
experimental	NULL
system	NULL
combining	NULL
adenovirus-mediated	NULL
gene	NULL
transfer	NULL
and	NULL
fetal	NULL
thymic	NULL
organ	NULL
culture	NULL
(	NULL
FTOC	NULL
)	NULL
.	NULL

This	NULL
system	NULL
allowed	NULL
us	NULL
to	NULL
efficiently	NULL
express	NULL
in	NULL
developing	NULL
thymocytes	NULL
a	NULL
mutant	NULL
form	NULL
of	NULL
the	NULL
NF-KB	NULL
inhibitor	NULL
IxBa	NULL
(	NULL
mut-IxB	NULL
)	NULL
and	NULL
to	NULL
study	NULL
the	NULL
maturation	NULL
defects	NULL
occurring	NULL
when	NULL
NF-KB	NULL
activation	NULL
is	NULL
inhibited	NULL
during	NULL
fetal	NULL
development	NULL
.	NULL

Fetal	NULL
thymocytes	NULL
infected	NULL
with	NULL
adenovirus	NULL
containing	NULL
mut-IxB	NULL
were	NULL
found	NULL
to	NULL
develop	NULL
normally	NULL
until	NULL
the	NULL
CD44-CD25¢	NULL
,	NULL
CD4~CD8~	NULL
double-negative	NULL
stage	NULL
,	NULL
while	NULL
production	NULL
of	NULL
more	NULL
mature	NULL
double-positive	NULL
and	NULL
single-positive	NULL
populations	NULL
was	NULL
strongly	NULL
decreased	NULL
.	NULL

Proliferation	NULL
,	NULL
as	NULL
measured	NULL
by	NULL
the	NULL
percentage	NULL
of	NULL
cells	NULL
in	NULL
cycle	NULL
appeared	NULL
normal	NULL
,	NULL
as	NULL
did	NULL
rearrangement	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
TCR	NULL
-chain	NULL
.	NULL

However	NULL
,	NULL
apoptosis	NULL
was	NULL
much	NULL
higher	NULL
in	NULL
FTOC	NULL
infected	NULL
with	NULL
adenovirus	NULL
containing	NULL
mut-IxB	NULL
than	NULL
in	NULL
FTOC	NULL
infected	NULL
with	NULL
a	NULL
control	NULL
virus	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
NF-B	NULL
plays	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
ensuring	NULL
the	NULL
differentiation	NULL
and	NULL
survival	NULL
of	NULL
thymocytes	NULL
in	NULL
the	NULL
early	NULL
stages	NULL
of	NULL
their	NULL
development	NULL
.	NULL

hymic	NULL
differentiation	NULL
starts	NULL
on	NULL
days	NULL
11-12	NULL
of	NULL
gestation	NULL
,	NULL
when	NULL
hemopoietic	NULL
stem	NULL
cells	NULL
from	NULL
the	NULL
yolk	NULL
sac	NULL
and	NULL
fetal	NULL
liver	NULL
start	NULL
to	NULL
populate	NULL
the	NULL
thymus	NULL
.	NULL

There	NULL
,	NULL
they	NULL
undergo	NULL
a	NULL
series	NULL
of	NULL
differentiation	NULL
steps	NULL
under	NULL
the	NULL
influence	NULL
of	NULL
their	NULL
interactions	NULL
with	NULL
stromal	NULL
cells	NULL
and	NULL
of	NULL
the	NULL
resulting	NULL
signaling	NULL
events	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Using	NULL
proteins	NULL
expressed	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
developing	NULL
thymocytes	NULL
as	NULL
markers	NULL
,	NULL
several	NULL
stages	NULL
in	NULL
development	NULL
can	NULL
be	NULL
detected	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

As	NULL
stem	NULL
cells	NULL
expressing	NULL
low	NULL
levels	NULL
of	NULL
CD4	NULL
migrate	NULL
into	NULL
the	NULL
cortex	NULL
of	NULL
the	NULL
thymus	NULL
,	NULL
they	NULL
down-regulate	NULL
CD4	NULL
and	NULL
become	NULL
CD4-CD8~	NULL
(	NULL
DN	NULL
)	NULL
prothymocytes	NULL
,	NULL
which	NULL
express	NULL
CD44	NULL
but	NULL
not	NULL
CD25	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Then	NULL
CD25	NULL
is	NULL
up-regulated	NULL
,	NULL
closely	NULL
followed	NULL
by	NULL
down-regulation	NULL
of	NULL
CD44	NULL
.	NULL

As	NULL
DN	NULL
thymocytes	NULL
reach	NULL
their	NULL
most	NULL
mature	NULL
state	NULL
,	NULL
expression	NULL
of	NULL
CD25	NULL
is	NULL
gradually	NULL
lost	NULL
(	NULL
4	NULL
)	NULL
.	NULL

During	NULL
the	NULL
DN	NULL
stage	NULL
,	NULL
the	NULL
TCRB	NULL
gene	NULL
is	NULL
rearranged	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
,	NULL
and	NULL
upon	NULL
expression	NULL
of	NULL
the	NULL
pTa	NULL
gene	NULL
product	NULL
,	NULL
as	NULL
part	NULL
of	NULL
the	NULL
pre-TCR	NULL
complex	NULL
,	NULL
further	NULL
differentiation	NULL
and	NULL
expansion	NULL
occur	NULL
(	NULL
7	NULL
)	NULL
.	NULL

After	NULL
transition	NULL
through	NULL
an	NULL
immature	NULL
single-positive	NULL
(	NULL
SP	NULL
)	NULL
stage	NULL
,	NULL
during	NULL
which	NULL
CD8	NULL
is	NULL
expressed	NULL
but	NULL
not	NULL
the	NULL
mature	NULL
TCR	NULL
,	NULL
cells	NULL
become	NULL
double	NULL
positive	NULL
(	NULL
DP	NULL
)	NULL
,	NULL
expressing	NULL
both	NULL
CD4	NULL
and	NULL
CD8	NULL
.	NULL

At	NULL
this	NULL
stage	NULL
TCRa	NULL
is	NULL
rearranged	NULL
,	NULL
and	NULL
a	NULL
mature	NULL
TCRaf	NULL
is	NULL
expressed	NULL
at	NULL
intermediate	NULL
levels	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
.	NULL

Next	NULL
,	NULL
the	NULL
cells	NULL
move	NULL
to	NULL
the	NULL
medulla	NULL
through	NULL
the	NULL
cortico-medullary	NULL
junction	NULL
where	NULL
they	NULL
are	NULL
positively	NULL
selected	NULL
for	NULL
self-MHC	NULL
recognition	NULL
and	NULL
negatively	NULL
selected	NULL
for	NULL
recognition	NULL
of	NULL
*Ludwig	NULL
Institute	NULL
for	NULL
Cancer	NULL
Research	NULL
,	NULL
Lausanne	NULL
Branch	NULL
,	NULL
University	NULL
of	NULL
Lausanne	NULL
,	NULL
Lausanne	NULL
,	NULL
Switzerland	NULL
;	NULL
and	NULL
*Swiss	NULL
Institute	NULL
for	NULL
Experimental	NULL
Cancer	NULL
Research	NULL
,	NULL
Epalinges	NULL
,	NULL
Switzerland	NULL
Received	NULL
for	NULL
publication	NULL
August	NULL
10	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
December	NULL
10	NULL
,	NULL
1998	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
Current	NULL
address	NULL
:	NULL
Centre	NULL
d	NULL
'	NULL
Immunologie	NULL
Pierre	NULL
Fabre	NULL
,	NULL
5	NULL
ave.	NULL
Napoleon-III	NULL
,	NULL
B.P	NULL
.	NULL

97	NULL
,	NULL
74164	NULL
Saint-Julien	NULL
en	NULL
Genevois	NULL
Cedex	NULL
,	NULL
France	NULL
.	NULL

2	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
C.	NULL
V.	NULL
Jongeneel	NULL
,	NULL
Ludwig	NULL
Institute	NULL
for	NULL
Cancer	NULL
Research	NULL
,	NULL
chemin	NULL
des	NULL
Boveresses	NULL
155	NULL
,	NULL
1066	NULL
Epalinges	NULL
,	NULL
Switzerland	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
victor.jongenee	NULL
@	NULL
isrec.unil.ch	NULL
3	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
DN	NULL
,	NULL
double	NULL
negative	NULL
;	NULL
SP	NULL
,	NULL
single	NULL
positive	NULL
;	NULL
DP	NULL
,	NULL
double	NULL
positive	NULL
;	NULL
FTOC	NULL
,	NULL
fetal	NULL
thymic	NULL
organ	NULL
culture	NULL
;	NULL
pfu	NULL
,	NULL
plaque-forming	NULL
units	NULL
;	NULL
PE	NULL
,	NULL
phycoerythrin	NULL
;	NULL
BrdU	NULL
,	NULL
bromodeoxyuridine	NULL
;	NULL
TUNEL	NULL
,	NULL
terminal	NULL
deoxynucleotidyltrans-ferase-mediated	NULL
UTP	NULL
end	NULL
labeling	NULL
;	NULL
B-gal	NULL
,	NULL
B-galactosidase	NULL
;	NULL
RAG	NULL
,	NULL
recombinase-acti-vating	NULL
gene	NULL
.	NULL

Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1999	NULL
,	NULL
162	NULL
:	NULL
3456-3462.	NULL
self	NULL
peptides	NULL
.	NULL

Finally	NULL
,	NULL
either	NULL
the	NULL
CD4	NULL
or	NULL
the	NULL
CD8	NULL
coreceptor	NULL
is	NULL
down-regulated	NULL
,	NULL
and	NULL
is	NULL
up-regulated	NULL
to	NULL
form	NULL
mature	NULL
,	NULL
SP	NULL
cells	NULL
that	NULL
ultimately	NULL
migrate	NULL
to	NULL
the	NULL
periphery	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

The	NULL
differentiation	NULL
steps	NULL
described	NULL
above	NULL
result	NULL
from	NULL
a	NULL
sequence	NULL
of	NULL
signaling	NULL
events	NULL
.	NULL

Among	NULL
candidate	NULL
mediators	NULL
of	NULL
maturation	NULL
signals	NULL
are	NULL
members	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
family	NULL
NF-	NULL
«	NULL
B/Rel	NULL
.	NULL

NF-KB	NULL
is	NULL
a	NULL
ubiquitous	NULL
,	NULL
constitutively	NULL
expressed	NULL
factor	NULL
that	NULL
is	NULL
normally	NULL
kept	NULL
in	NULL
an	NULL
inactive	NULL
form	NULL
in	NULL
the	NULL
cytoplasm	NULL
by	NULL
IB	NULL
.	NULL

Upon	NULL
receiving	NULL
an	NULL
activation	NULL
signal	NULL
,	NULL
IB	NULL
is	NULL
rapidly	NULL
phosphorylated	NULL
and	NULL
degraded	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
then	NULL
moves	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
where	NULL
it	NULL
induces	NULL
the	NULL
transcription	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
genes	NULL
(	NULL
10-12	NULL
)	NULL
.	NULL

A	NULL
role	NULL
for	NULL
NF-KB	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
thymocyte	NULL
development	NULL
is	NULL
suggested	NULL
by	NULL
its	NULL
high	NULL
expression	NULL
in	NULL
the	NULL
thymus	NULL
and	NULL
the	NULL
fact	NULL
that	NULL
NF-KB	NULL
family	NULL
members	NULL
are	NULL
differentially	NULL
expressed	NULL
in	NULL
the	NULL
thymic	NULL
compartments	NULL
;	NULL
RelA	NULL
is	NULL
expressed	NULL
in	NULL
the	NULL
cortex	NULL
,	NULL
while	NULL
ReIB	NULL
and	NULL
c-Rel	NULL
are	NULL
preferentially	NULL
expressed	NULL
in	NULL
the	NULL
medulla	NULL
(	NULL
13-15	NULL
)	NULL
.	NULL

Several	NULL
groups	NULL
have	NULL
tried	NULL
to	NULL
elucidate	NULL
the	NULL
role	NULL
of	NULL
NF-KB	NULL
in	NULL
thymocyte	NULL
development	NULL
by	NULL
studying	NULL
mice	NULL
deficient	NULL
in	NULL
the	NULL
genes	NULL
coding	NULL
for	NULL
individual	NULL
family	NULL
members	NULL
or	NULL
by	NULL
overexpressing	NULL
factors	NULL
that	NULL
inhibit	NULL
NF-KB	NULL
activation	NULL
.	NULL

Mice	NULL
deficient	NULL
for	NULL
individual	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

l	NULL
subunits	NULL
exhibit	NULL
no	NULL
intrinsic	NULL
defects	NULL
in	NULL
T	NULL
cell	NULL
development	NULL
.	NULL

However	NULL
,	NULL
gene	NULL
targeting	NULL
approaches	NULL
are	NULL
complicated	NULL
by	NULL
the	NULL
functional	NULL
redundancy	NULL
that	NULL
exists	NULL
in	NULL
the	NULL
family	NULL
;	NULL
for	NULL
example	NULL
,	NULL
complexes	NULL
containing	NULL
either	NULL
c-Rel	NULL
or	NULL
RelA	NULL
have	NULL
the	NULL
potential	NULL
to	NULL
stimulate	NULL
transcription	NULL
from	NULL
the	NULL
same	NULL
promoter	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

To	NULL
circumvent	NULL
this	NULL
problem	NULL
two	NULL
groups	NULL
have	NULL
recently	NULL
made	NULL
transgenic	NULL
mice	NULL
expressing	NULL
the	NULL
NF-KB	NULL
inhibitor	NULL
I	NULL
«	NULL
kBa	NULL
under	NULL
a	NULL
lymphocyte-specific	NULL
promoter	NULL
.	NULL

This	NULL
inhibitor	NULL
functions	NULL
as	NULL
a	NULL
constitutive	NULL
repressor	NULL
of	NULL
multiple	NULL
NF-	NULL
«	NULL
B/Rel	NULL
proteins	NULL
.	NULL

Although	NULL
it	NULL
was	NULL
shown	NULL
that	NULL
the	NULL
total	NULL
number	NULL
of	NULL
thymocytes	NULL
was	NULL
decreased	NULL
in	NULL
these	NULL
mice	NULL
and	NULL
that	NULL
there	NULL
was	NULL
a	NULL
defect	NULL
in	NULL
their	NULL
development	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
,	NULL
this	NULL
system	NULL
does	NULL
not	NULL
allow	NULL
us	NULL
to	NULL
pinpoint	NULL
the	NULL
exact	NULL
developmental	NULL
stage	NULL
at	NULL
which	NULL
NF-KB	NULL
is	NULL
involved	NULL
.	NULL

We	NULL
used	NULL
a	NULL
novel	NULL
technique	NULL
combining	NULL
adenovirus-mediated	NULL
gene	NULL
transfer	NULL
and	NULL
fetal	NULL
thymic	NULL
organ	NULL
culture	NULL
(	NULL
FTOC	NULL
)	NULL
to	NULL
determine	NULL
at	NULL
which	NULL
stage	NULL
of	NULL
fetal	NULL
thymic	NULL
development	NULL
NF-KB	NULL
is	NULL
critical	NULL
.	NULL

We	NULL
infected	NULL
FTOC	NULL
with	NULL
an	NULL
adenovirus	NULL
containing	NULL
an	NULL
IB	NULL
cDNA	NULL
(	NULL
mut-IkB	NULL
)	NULL
from	NULL
which	NULL
the	NULL
N-terminal	NULL
phosphorylation	NULL
sites	NULL
have	NULL
been	NULL
removed	NULL
,	NULL
resulting	NULL
in	NULL
an	NULL
IB	NULL
with	NULL
a	NULL
prolonged	NULL
half-life	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Using	NULL
this	NULL
technique	NULL
,	NULL
we	NULL
show	NULL
that	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
results	NULL
in	NULL
impaired	NULL
transition	NULL
from	NULL
the	NULL
*	NULL
to	NULL
the	NULL
CD44	NULL
~CD25~	NULL
developmental	NULL
stage	NULL
and	NULL
an	NULL
increased	NULL
sensitivity	NULL
to	NULL
apoptosis	NULL
.	NULL

0022-1767/99/	NULL
$	NULL
02.00	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
Table	NULL
I	NULL
.	NULL

-	NULL
Effects	NULL
of	NULL
viral	NULL
infection	NULL
on	NULL
cell	NULL
recovery	NULL
in	NULL
FTOC	NULL
FTOC	NULL
Condition	NULL
Total	NULL
Cell	NULL
Recovery	NULL
per	NULL
Lobe	NULL
Noninfected	NULL
C57B1/6	NULL
3.6	NULL
+	NULL
1.0	NULL
x	NULL
10+	NULL
AdCMVB-gal	NULL
10	NULL
``	NULL
pfu/well	NULL
3.2	NULL
+	NULL
0.9	NULL
x	NULL
10+	NULL
AdCMVB-gal	NULL
10°	NULL
pfu/well	NULL
2.9	NULL
+	NULL
1.0	NULL
x	NULL
10+	NULL
AdCMVmut-IxB	NULL
10	NULL
``	NULL
pfu/well	NULL
1.6	NULL
+	NULL
0.7	NULL
x	NULL
10+	NULL
AdCMVmut-IxB	NULL
10°	NULL
pfu/well	NULL
0.9	NULL
+	NULL
0.4	NULL
x	NULL
10+	NULL
IxBa	NULL
transgenic	NULL
2.2	NULL
+	NULL
1.2	NULL
x	NULL
10+	NULL
``	NULL
Fetal	NULL
thymic	NULL
lobes	NULL
were	NULL
cultured	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
recombinant	NULL
adenoviruses	NULL
as	NULL
indicated	NULL
.	NULL

Cells	NULL
were	NULL
counted	NULL
after	NULL
6	NULL
days	NULL
in	NULL
culture	NULL
.	NULL

The	NULL
mean	NULL
and	NULL
standard	NULL
deviation	NULL
of	NULL
20	NULL
experiments	NULL
(	NULL
10	NULL
'	NULL
pfu/well	NULL
infec-tions	NULL
)	NULL
or	NULL
3	NULL
experiments	NULL
(	NULL
10°	NULL
pfu/well	NULL
infections	NULL
,	NULL
noninfected	NULL
and	NULL
transgenic	NULL
mice	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Construction	NULL
and	NULL
maintenance	NULL
of	NULL
recombinant	NULL
adenoviral	NULL
vectors	NULL
The	NULL
AdCMVB-gal	NULL
recombinant	NULL
virus	NULL
was	NULL
constructed	NULL
as	NULL
previosuly	NULL
described	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
a	NULL
3.5-kb	NULL
HindlW/BamHI	NULL
fragment	NULL
containing	NULL
the	NULL
Escherichia	NULL
coli	NULL
lacZ	NULL
gene	NULL
was	NULL
ligated	NULL
into	NULL
the	NULL
viral	NULL
plasmid	NULL
pACCMV95	NULL
to	NULL
produce	NULL
pACB-gal	NULL
.	NULL

pACCMV95	NULL
contains	NULL
the	NULL
5	NULL
``	NULL
6242	NULL
bp	NULL
of	NULL
Ad-5	NULL
from	NULL
which	NULL
the	NULL
region	NULL
454-3328	NULL
bp	NULL
has	NULL
been	NULL
deleted	NULL
(	NULL
the	NULL
deletion	NULL
incorporates	NULL
all	NULL
of	NULL
the	NULL
E1A	NULL
and	NULL
part	NULL
of	NULL
the	NULL
E1B	NULL
region	NULL
)	NULL
and	NULL
includes	NULL
a	NULL
CMV	NULL
interme-diate-early	NULL
promoter	NULL
upstream	NULL
of	NULL
the	NULL
cloning	NULL
site	NULL
and	NULL
an	NULL
SV40	NULL
polyade-nylation	NULL
signal	NULL
downstream	NULL
.	NULL

The	NULL
pACB-gal	NULL
was	NULL
cotransfected	NULL
together	NULL
with	NULL
JM17	NULL
(	NULL
which	NULL
contains	NULL
an	NULL
Ad-5	NULL
viral	NULL
backbone	NULL
)	NULL
into	NULL
293	NULL
cells	NULL
.	NULL

Ho-mologous	NULL
recombination	NULL
between	NULL
the	NULL
two	NULL
plasmids	NULL
resulted	NULL
in	NULL
the	NULL
production	NULL
of	NULL
infectious	NULL
recombinant	NULL
adenovirus	NULL
expressing	NULL
the	NULL
bacterial	NULL
B-ga-lactosidase	NULL
(	NULL
-gal	NULL
)	NULL
protein	NULL
.	NULL

A	NULL
similar	NULL
strategy	NULL
was	NULL
used	NULL
to	NULL
create	NULL
AdCMVmut-I	NULL
«	NULL
B	NULL
(	NULL
22	NULL
)	NULL
.	NULL

To	NULL
make	NULL
the	NULL
mut-I	NULL
«	NULL
B	NULL
construct	NULL
,	NULL
the	NULL
Xho-BamHI	NULL
fragment	NULL
of	NULL
MAD3pBS	NULL
(	NULL
containing	NULL
a	NULL
human	NULL
IxBa	NULL
cDNA	NULL
lacking	NULL
phosphorylation	NULL
sites	NULL
)	NULL
(	NULL
20	NULL
)	NULL
was	NULL
ligated	NULL
to	NULL
the	NULL
nuclear	NULL
localization	NULL
sequence	NULL
of	NULL
the	NULL
proto-oncogene	NULL
c-myc	NULL
.	NULL

The	NULL
blunt/Xbal	NULL
fragment	NULL
containing	NULL
mut-IxB	NULL
without	NULL
a	NULL
promoter	NULL
was	NULL
then	NULL
ligated	NULL
into	NULL
the	NULL
viral	NULL
plasmid	NULL
pACCMV95	NULL
and	NULL
cotransfected	NULL
with	NULL
JM17	NULL
into	NULL
293	NULL
cells	NULL
.	NULL

Transfected	NULL
293	NULL
cells	NULL
were	NULL
harvested	NULL
,	NULL
and	NULL
individual	NULL
plaques	NULL
were	NULL
isolated	NULL
and	NULL
purified	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Large	NULL
stocks	NULL
were	NULL
produced	NULL
and	NULL
concentrated	NULL
before	NULL
being	NULL
titrated	NULL
by	NULL
plaque	NULL
and	NULL
limiting	NULL
dilution	NULL
assays	NULL
.	NULL

Concentrated	NULL
stocks	NULL
typically	NULL
had	NULL
titers	NULL
in	NULL
the	NULL
range	NULL
of	NULL
10°-10'°	NULL
pfu/ml	NULL
.	NULL

Mice	NULL
Pregnant	NULL
C57BL/6	NULL
mice	NULL
were	NULL
purchased	NULL
from	NULL
Harlan	NULL
CPB	NULL
(	NULL
Zeist	NULL
,	NULL
The	NULL
Netherlands	NULL
)	NULL
or	NULL
were	NULL
bred	NULL
under	NULL
standard	NULL
conditions	NULL
in	NULL
the	NULL
animal	NULL
facilities	NULL
of	NULL
the	NULL
Swiss	NULL
Institute	NULL
for	NULL
Experimental	NULL
Cancer	NULL
Research	NULL
(	NULL
Epalinges	NULL
,	NULL
Swit-zerland	NULL
)	NULL
.	NULL

IxBa	NULL
:	NULL
transgenic	NULL
mice	NULL
(	NULL
18	NULL
)	NULL
were	NULL
generated	NULL
and	NULL
bred	NULL
under	NULL
standard	NULL
conditions	NULL
.	NULL

Fetal	NULL
thymus	NULL
organ	NULL
culture	NULL
Fetal	NULL
thymi	NULL
were	NULL
isolated	NULL
from	NULL
C57BL/6	NULL
mice	NULL
or	NULL
IxBa	NULL
transgenic	NULL
mice	NULL
on	NULL
day	NULL
14	NULL
of	NULL
gestation	NULL
and	NULL
transferred	NULL
to	NULL
membranes	NULL
of	NULL
a	NULL
transwell	NULL
system	NULL
(	NULL
Costar	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Eight	NULL
to	NULL
ten	NULL
lobes	NULL
were	NULL
cultured	NULL
per	NULL
well	NULL
.	NULL

The	NULL
lower	NULL
compartment	NULL
was	NULL
filled	NULL
with	NULL
complete	NULL
DMEM-10	NULL
medium	NULL
(	NULL
24	NULL
)	NULL
containing	NULL
2-ME	NULL
and	NULL
10	NULL
``	NULL
pfu	NULL
of	NULL
either	NULL
AdCMVmut-IxB	NULL
or	NULL
AdCMVB-gal	NULL
.	NULL

To	NULL
obtain	NULL
the	NULL
data	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
Table	NULL
I	NULL
,	NULL
either	NULL
10	NULL
``	NULL
or	NULL
10°	NULL
pfu	NULL
of	NULL
virus	NULL
was	NULL
used	NULL
.	NULL

Both	NULL
medium	NULL
and	NULL
virus	NULL
were	NULL
changed	NULL
every	NULL
3	NULL
days	NULL
.	NULL

After	NULL
6	NULL
days	NULL
or	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
,	NULL
thymic	NULL
lobes	NULL
were	NULL
harvested	NULL
and	NULL
mechanically	NULL
disrupted	NULL
.	NULL

Approximately	NULL
80	NULL
lobes/experiment	NULL
were	NULL
ana-lyzed	NULL
,	NULL
which	NULL
were	NULL
normally	NULL
divided	NULL
into	NULL
pools	NULL
of	NULL
eight	NULL
lobes	NULL
.	NULL

Single	NULL
cells	NULL
were	NULL
stained	NULL
and	NULL
analyzed	NULL
by	NULL
FACS	NULL
.	NULL

Abs	NULL
and	NULL
flow	NULL
cytometry	NULL
Single-cell	NULL
suspensions	NULL
of	NULL
thymocytes	NULL
were	NULL
incubated	NULL
on	NULL
ice	NULL
with	NULL
saturating	NULL
concentrations	NULL
of	NULL
the	NULL
following	NULL
Abs	NULL
:	NULL
anti-CD4-CyChrome	NULL
,	NULL
anti-CD4-PE	NULL
,	NULL
anti-CD8-CyChrome	NULL
,	NULL
anti-CD3-PE	NULL
,	NULL
anti-TCRaB-PE	NULL
,	NULL
anti-TCRof-CyChrome	NULL
,	NULL
and	NULL
anti-CD44-CyChrome	NULL
(	NULL
PharMingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
;	NULL
hamster	NULL
IgG-PE	NULL
,	NULL
anti-TCRy8	NULL
tri-color	NULL
and	NULL
anti-CD25-PE	NULL
(	NULL
Caltag	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
;	NULL
anti-CD4-R613	NULL
and	NULL
anti-CD8-R613	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
;	NULL
FITC-labeled	NULL
anti-CD44	NULL
(	NULL
Pgp-1	NULL
)	NULL
(	NULL
25	NULL
)	NULL
;	NULL
and	NULL
FITC-labeled	NULL
anti-CD8	NULL
H35	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Intracellular	NULL
staining	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Three-	NULL
and	NULL
four-color	NULL
analyses	NULL
were	NULL
performed	NULL
on	NULL
3457	NULL
FACScan	NULL
and	NULL
FACStar	NULL
Plus	NULL
cytofluorometers	NULL
,	NULL
respectively	NULL
,	NULL
using	NULL
LYSIS	NULL
II	NULL
software	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Fluorescent	NULL
-gal	NULL
assay	NULL
Detection	NULL
of	NULL
B-gal	NULL
by	NULL
FACS	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Cells	NULL
previously	NULL
stained	NULL
with	NULL
surface	NULL
Abs	NULL
were	NULL
incubated	NULL
at	NULL
a	NULL
density	NULL
of	NULL
10-10	NULL
``	NULL
cells/ml	NULL
in	NULL
100	NULL
l	NULL
of	NULL
PBS/FCS	NULL
during	NULL
5	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Then	NULL
they	NULL
were	NULL
hypotonically	NULL
loaded	NULL
with	NULL
the	NULL
B-gal	NULL
substrate	NULL
,	NULL
fluorescein	NULL
di-B-	NULL
»	NULL
-galactopyranoside	NULL
(	NULL
Sigma	NULL
,	NULL
Buchs	NULL
,	NULL
Switzerland	NULL
)	NULL
,	NULL
for	NULL
1	NULL
min	NULL
.	NULL

Loading	NULL
was	NULL
stopped	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
PBS	NULL
containing	NULL
300	NULL
uM	NULL
chloroquine	NULL
.	NULL

After	NULL
1	NULL
h	NULL
of	NULL
incubation	NULL
on	NULL
ice	NULL
,	NULL
cells	NULL
were	NULL
analyzed	NULL
by	NULL
FACS	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
Fetal	NULL
thymocytes	NULL
were	NULL
put	NULL
into	NULL
culture	NULL
and	NULL
were	NULL
infected	NULL
with	NULL
either	NULL
AdCMVB-gal	NULL
or	NULL
After	NULL
2	NULL
days	NULL
,	NULL
thymocytes	NULL
were	NULL
harvested	NULL
,	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
on	NULL
crude	NULL
nuclear	NULL
extracts	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
°°P-labeled	NULL
double-stranded	NULL
oligonucleotide	NULL
derived	NULL
from	NULL
the	NULL
«	NULL
B	NULL
enhancer	NULL
of	NULL
the	NULL
mouse	NULL
light	NULL
chain	NULL
locus	NULL
before	NULL
separation	NULL
in	NULL
an	NULL
8	NULL
%	NULL
acrylamide	NULL
gel	NULL
in	NULL
0.25	NULL
%	NULL
TBE	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
probe	NULL
trapped	NULL
in	NULL
a	NULL
DNA/	NULL
protein	NULL
complex	NULL
was	NULL
quantitated	NULL
by	NULL
exposing	NULL
the	NULL
dried	NULL
gel	NULL
to	NULL
an	NULL
imaging	NULL
plate	NULL
of	NULL
an	NULL
autoradiography	NULL
system	NULL
(	NULL
BAS	NULL
,	NULL
Fuji	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

Protein	NULL
concentrations	NULL
in	NULL
extracts	NULL
were	NULL
determined	NULL
using	NULL
the	NULL
bicinchoninic	NULL
acid	NULL
protein	NULL
assay	NULL
(	NULL
Pierce	NULL
,	NULL
Rockford	NULL
,	NULL
IL	NULL
)	NULL
to	NULL
ensure	NULL
equal	NULL
loading	NULL
.	NULL

Bromodeoxyuridine	NULL
(	NULL
BrdU	NULL
)	NULL
assay	NULL
To	NULL
detect	NULL
cell	NULL
proliferation	NULL
,	NULL
BrdU	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
cultures	NULL
10	NULL
h	NULL
before	NULL
harvest	NULL
.	NULL

Thymic	NULL
lobes	NULL
were	NULL
mechanically	NULL
disrupted	NULL
,	NULL
and	NULL
single	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
Abs	NULL
detecting	NULL
cell	NULL
surface	NULL
Ags	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
resus-pended	NULL
in	NULL
25	NULL
ul	NULL
of	NULL
0.15	NULL
M	NULL
NaCl	NULL
,	NULL
after	NULL
which	NULL
70	NULL
ul	NULL
of	NULL
ice-cold	NULL
95	NULL
%	NULL
ethanol	NULL
was	NULL
added	NULL
.	NULL

After	NULL
30	NULL
min	NULL
incubation	NULL
on	NULL
ice	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
incubated	NULL
in	NULL
100	NULL
pl	NULL
of	NULL
PBS	NULL
containing	NULL
1	NULL
%	NULL
paraformaldehyde	NULL
and	NULL
0.01	NULL
%	NULL
Tween-20	NULL
.	NULL

Fixed	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
stained	NULL
with	NULL
anti-BrdU-FITC	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
0.5	NULL
%	NULL
Tween	NULL
after	NULL
blocking	NULL
nonspe-cific	NULL
binding	NULL
with	NULL
rabbit	NULL
anti-mouse	NULL
IgG	NULL
for	NULL
1	NULL
h.	NULL
Cell	NULL
cycle	NULL
analysis	NULL
Different	NULL
populations	NULL
within	NULL
the	NULL
DN	NULL
compartment	NULL
were	NULL
sorted	NULL
by	NULL
FACS	NULL
.	NULL

Cell	NULL
suspensions	NULL
were	NULL
then	NULL
fixed	NULL
with	NULL
70	NULL
%	NULL
ethanol	NULL
at	NULL
4°C	NULL
for	NULL
30	NULL
min	NULL
,	NULL
washed	NULL
in	NULL
PBS	NULL
,	NULL
and	NULL
stained	NULL
with	NULL
50	NULL
g/ml	NULL
propidium	NULL
iodide	NULL
.	NULL

DNA	NULL
content	NULL
was	NULL
analyzed	NULL
using	NULL
doublet	NULL
discrimination	NULL
on	NULL
FACS	NULL
.	NULL

Quantitation	NULL
of	NULL
apoptosis	NULL
by	NULL
annexin	NULL
V-FITC	NULL
To	NULL
quantify	NULL
apoptosis	NULL
,	NULL
thymic	NULL
lobes	NULL
were	NULL
mechanically	NULL
disrupted	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
1	NULL
h.	NULL
After	NULL
incubation	NULL
,	NULL
10°-10°	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
100	NULL
pl	NULL
of	NULL
binding	NULL
buffer	NULL
.	NULL

Then	NULL
they	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
1/500	NULL
dilution	NULL
of	NULL
annexin	NULL
V-FITC	NULL
(	NULL
NeXins	NULL
Research	NULL
,	NULL
Leiden	NULL
,	NULL
The	NULL
Netherlands	NULL
)	NULL
for	NULL
20	NULL
min	NULL
on	NULL
ice	NULL
before	NULL
apoptosis	NULL
was	NULL
quantified	NULL
by	NULL
FACS	NULL
.	NULL

Quantitation	NULL
of	NULL
apoptosis	NULL
by	NULL
TUNEL	NULL
Thymic	NULL
lobes	NULL
were	NULL
mechanically	NULL
disrupted	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
3	NULL
h.	NULL
Cells	NULL
undergoing	NULL
DNA	NULL
fragmentation	NULL
were	NULL
detected	NULL
with	NULL
the	NULL
TUNEL	NULL
method	NULL
(	NULL
terminal	NULL
deoxyribonucleotidy	NULL
]	NULL
transferase	NULL
labeling	NULL
of	NULL
DNA	NULL
strand	NULL
breaks	NULL
with	NULL
BrdU	NULL
;	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
)	NULL
,	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Stained	NULL
cells	NULL
were	NULL
analyzed	NULL
by	NULL
FACS	NULL
.	NULL

Results	NULL
Infection	NULL
of	NULL
fetal	NULL
thymocytes	NULL
with	NULL
adenovirus	NULL
To	NULL
assess	NULL
the	NULL
role	NULL
of	NULL
NF-KB	NULL
in	NULL
fetal	NULL
thymocyte	NULL
development	NULL
,	NULL
we	NULL
developed	NULL
a	NULL
system	NULL
for	NULL
adenovirus-mediated	NULL
gene	NULL
expression	NULL
in	NULL
FTOC	NULL
.	NULL

To	NULL
monitor	NULL
whether	NULL
fetal	NULL
thymocytes	NULL
can	NULL
be	NULL
infected	NULL
with	NULL
adenovirus	NULL
,	NULL
fetal	NULL
thymi	NULL
were	NULL
placed	NULL
in	NULL
culture	NULL
on	NULL
days	NULL
14-15	NULL
of	NULL
gestation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
``	NULL
pfu	NULL
AdCMVB-gal	NULL
.	NULL

This	NULL
virus	NULL
directs	NULL
expression	NULL
of	NULL
B-gal	NULL
,	NULL
allowing	NULL
easy	NULL
monitoring	NULL
of	NULL
infection	NULL
based	NULL
on	NULL
enzymatic	NULL
activity	NULL
.	NULL

Fetal	NULL
thymi	NULL
cultured	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
``	NULL
pfu	NULL
AdCMVmut-IxB	NULL
were	NULL
used	NULL
as	NULL
a	NULL
control	NULL
for	NULL
the	NULL
B-gal	NULL
assay	NULL
.	NULL

At	NULL
different	NULL
times	NULL
after	NULL
infection	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
treated	NULL
with	NULL
a	NULL
-gal	NULL
substrate	NULL
(	NULL
fluorescein	NULL
di-B	NULL
--	NULL
galactopyranoside	NULL
)	NULL
that	NULL
fluoresces	NULL
after	NULL
cleavage	NULL
,	NULL
and	NULL
fluorescence	NULL
was	NULL
measured	NULL
by	NULL
FACS	NULL
.	NULL

Virtually	NULL
all	NULL
fetal	NULL
thymocytes	NULL
cultured	NULL
with	NULL
AdCMVB-gal	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
hatched	NULL
histograms	NULL
)	NULL
showed	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
3458	NULL
A	NULL
B-gal	NULL
_	NULL
mut-	NULL
!	NULL

xB	NULL
riffs	NULL
B	NULL
<	NULL
+	NULL
§	NULL
co	NULL
«	NULL
cos	NULL
8	NULL
CD4-coe+	NULL
E	NULL
10	NULL
10	NULL
1C	NULL
10	NULL
10	NULL
10	NULL
10	NULL
iG	NULL
10	NULL
10	NULL
>	NULL
|	NULL
&	NULL
a	NULL
w	NULL
|	NULL
-	NULL
CD4	NULL
SP	NULL
=-	NULL
CD8	NULL
SP	NULL
o	NULL
®	NULL
10	NULL
1G	NULL
10	NULL
10	NULL
10	NULL
100	NULL
iG	NULL
10	NULL
10	NULL
B-galactosidase-specific	NULL
fluorescence	NULL
(	NULL
log	NULL
)	NULL
FIGURE	NULL
1	NULL
.	NULL

Infection	NULL
of	NULL
fetal	NULL
thymocytes	NULL
by	NULL
AdCMVmut-IB	NULL
and	NULL
in	NULL
hibition	NULL
of	NULL
NF-KB	NULL
activity	NULL
.	NULL

A	NULL
,	NULL
Inhibition	NULL
of	NULL
NF-B	NULL
activity	NULL
in	NULL
fetal	NULL
thymocytes	NULL
infected	NULL
with	NULL
AdCMVmut-IxB	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
fetal	NULL
thymocytes	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
AdCMV	NULL
B-gal	NULL
or	NULL
were	NULL
assayed	NULL
for	NULL
NF-KB	NULL
activity	NULL
.	NULL

Protein	NULL
levels	NULL
in	NULL
extracts	NULL
were	NULL
determined	NULL
using	NULL
the	NULL
bicinchoninic	NULL
acid	NULL
protein	NULL
assay	NULL
to	NULL
ensure	NULL
equal	NULL
loading	NULL
.	NULL

Upper	NULL
arrow	NULL
,	NULL
ReIA/NF-	NULL
«	NULL
BI1	NULL
and	NULL
c-Rel/NF-	NULL
«	NULL
B1	NULL
heterodimers	NULL
.	NULL

Lower	NULL
arrow	NULL
,	NULL
NF-	NULL
«	NULL
B1	NULL
homodimers	NULL
.	NULL

B	NULL
,	NULL
Infection	NULL
of	NULL
fetal	NULL
thymocytes	NULL
.	NULL

Fetal	NULL
thymic	NULL
lobes	NULL
were	NULL
cultured	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

After	NULL
4	NULL
days	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
stained	NULL
with	NULL
anti-CD4	NULL
and	NULL
anti-CD8	NULL
and	NULL
incubated	NULL
with	NULL
fluorescein	NULL
di-B-p-galactopyranoside	NULL
.	NULL

Expression	NULL
of	NULL
B-gal	NULL
in	NULL
different	NULL
subpopulations	NULL
was	NULL
analyzed	NULL
by	NULL
FACS	NULL
.	NULL

Hatched	NULL
histograms	NULL
,	NULL
Thymocytes	NULL
infected	NULL
with	NULL
AdCMVB-gal	NULL
.	NULL

Empty	NULL
histograms	NULL
,	NULL
Thymocytes	NULL
infected	NULL
with	NULL
AdCMVmut-IKB	NULL
;	NULL
fluorescent	NULL
staining	NULL
regardless	NULL
of	NULL
their	NULL
stage	NULL
of	NULL
maturation	NULL
,	NULL
while	NULL
control	NULL
thymocytes	NULL
infected	NULL
with	NULL
10	NULL
``	NULL
pfu	NULL
AdCMVmut-IxB	NULL
remained	NULL
negative	NULL
(	NULL
empty	NULL
histograms	NULL
)	NULL
.	NULL

Similar	NULL
infection	NULL
levels	NULL
were	NULL
found	NULL
at	NULL
all	NULL
time	NULL
points	NULL
analyzed	NULL
(	NULL
after	NULL
2	NULL
,	NULL
4	NULL
,	NULL
6	NULL
,	NULL
or	NULL
7	NULL
days	NULL
of	NULL
cul-ture	NULL
)	NULL
,	NULL
and	NULL
development	NULL
kinetics	NULL
of	NULL
AdCMV	NULL
B-gal-infected	NULL
thymocytes	NULL
were	NULL
comparable	NULL
to	NULL
those	NULL
of	NULL
uninfected	NULL
thymocytes	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

NF-KB	NULL
in	NULL
fetal	NULL
thymocyte	NULL
development	NULL
To	NULL
investigate	NULL
the	NULL
influence	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
on	NULL
fetal	NULL
thymic	NULL
development	NULL
,	NULL
fetal	NULL
thymi	NULL
were	NULL
taken	NULL
on	NULL
days	NULL
14-15	NULL
of	NULL
gestation	NULL
,	NULL
transferred	NULL
to	NULL
Transwell	NULL
plates	NULL
(	NULL
Costar	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
,	NULL
and	NULL
infected	NULL
with	NULL
AdCMVmut-I	NULL
«	NULL
B	NULL
.	NULL

This	NULL
virus	NULL
expresses	NULL
a	NULL
mutant	NULL
IxBa	NULL
with	NULL
a	NULL
prolonged	NULL
half-life	NULL
,	NULL
which	NULL
functions	NULL
as	NULL
a	NULL
constitutive	NULL
repressor	NULL
of	NULL
NF-KB	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
fetal	NULL
thymocytes	NULL
cultured	NULL
for	NULL
2	NULL
days	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
viral	NULL
vector	NULL
revealed	NULL
a	NULL
fourfold	NULL
or	NULL
higher	NULL
reduction	NULL
in	NULL
the	NULL
more	NULL
slowly	NULL
migrating	NULL
,	NULL
active	NULL
form	NULL
of	NULL
NF-KB	NULL
in	NULL
the	NULL
AdCMVmut-I	NULL
«	NULL
B-infected	NULL
thymocytes	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Earlier	NULL
studies	NULL
had	NULL
shown	NULL
that	NULL
this	NULL
band	NULL
consists	NULL
of	NULL
a	NULL
mixture	NULL
of	NULL
RelA	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
presumably	NULL
RelB	NULL
complexed	NULL
to	NULL
NF-	NULL
«	NULL
B1/p50	NULL
(	NULL
14	NULL
,	NULL
15	NULL
,	NULL
30	NULL
)	NULL
.	NULL

Thymocyte	NULL
development	NULL
was	NULL
analyzed	NULL
after	NULL
6	NULL
days	NULL
of	NULL
culture	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
virus	NULL
and	NULL
compared	NULL
with	NULL
the	NULL
development	NULL
of	NULL
thymocytes	NULL
that	NULL
were	NULL
infected	NULL
with	NULL
the	NULL
control	NULL
virus	NULL
AdCMV	NULL
B-gal	NULL
.	NULL

Fig	NULL
.	NULL

2A	NULL
shows	NULL
that	NULL
in	NULL
the	NULL
thymocytes	NULL
infected	NULL
with	NULL
10	NULL
``	NULL
pfu	NULL
AdCMVmut-I	NULL
«	NULL
B	NULL
there	NULL
was	NULL
a	NULL
twofold	NULL
relative	NULL
increase	NULL
in	NULL
the	NULL
CD4	NULL
_~CD8~	NULL
DN	NULL
population	NULL
compared	NULL
with	NULL
that	NULL
in	NULL
thymocytes	NULL
infected	NULL
with	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
AdCMVB-gal	NULL
,	NULL
while	NULL
there	NULL
was	NULL
a	NULL
twofold	NULL
relative	NULL
decrease	NULL
in	NULL
the	NULL
DP	NULL
compartment	NULL
.	NULL

Although	NULL
less	NULL
pronounced	NULL
than	NULL
in	NULL
the	NULL
DP	NULL
population	NULL
,	NULL
a	NULL
decrease	NULL
could	NULL
also	NULL
be	NULL
NEF-	NULL
«	NULL
B	NULL
IN	NULL
FETAL	NULL
THYMOCYTE	NULL
DEVELOPMENT	NULL
mut-lxB	NULL
A	NULL
A	NULL
:	NULL
Low	NULL
-	NULL
-	NULL
virus	NULL
s	NULL
titer	NULL
if	NULL
.	NULL

e	NULL
“	NULL
Q	NULL
``	NULL
©	NULL
11	NULL
(	NULL
s	NULL
]	NULL
56a7.9	NULL
13	NULL
2o|16	NULL
(	NULL
24	NULL
24	NULL
(	NULL
7.7	NULL
)	NULL
9	NULL
(	NULL
29	NULL
)	NULL
66	NULL
(	NULL
9.9	NULL
)	NULL
|	NULL
5	NULL
(	NULL
0.75	NULL
)	NULL
CD8	NULL
B	NULL
High	NULL
virus	NULL
titer	NULL
_9	NULL
(	NULL
2760	NULL
(	NULL
18	NULL
)	NULL
_	NULL
_3	NULL
(	NULL
0.24	NULL
)	NULL
}	NULL
1	NULL
(	NULL
0.08	NULL
)	NULL
__	NULL
26	NULL
(	NULL
7.8	NULL
)	NULL
|	NULL
5	NULL
(	NULL
1.5	NULL
)	NULL
95	NULL
(	NULL
7.6	NULL
)	NULL
|	NULL
1	NULL
(	NULL
0.08	NULL
)	NULL
Cc	NULL
CD4	NULL
f	NULL
o	NULL
3	NULL
B	NULL
8	NULL
25	NULL
*	NULL
%	NULL
;	NULL
K	NULL
isp	NULL
:	NULL
+	NULL
4	NULL
,	NULL
|i	NULL
*	NULL
¥	NULL
§	NULL
'	NULL
f	NULL
--	NULL
-	NULL
:	NULL
e	NULL
E	NULL
o.5|	NULL
$	NULL
06	NULL
tf	NULL
2	NULL
.	NULL

B	NULL
i	NULL
o	NULL
i	NULL
£4	NULL
I	NULL
;	NULL
DN	NULL
ISP	NULL
_	NULL
DP	NULL
CD4	NULL
CD8	NULL
SP	NULL
SP	NULL
FIGURE	NULL
2	NULL
.	NULL

|	NULL
Impairment	NULL
of	NULL
thymocyte	NULL
maturation	NULL
to	NULL
the	NULL
DP	NULL
stage	NULL
.	NULL

Fetal	NULL
thymi	NULL
infected	NULL
with	NULL
either	NULL
AdCMVmut-IxB	NULL
or	NULL
AdCMVB-gal	NULL
were	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
after	NULL
6	NULL
days	NULL
of	NULL
culture	NULL
.	NULL

Thymocytes	NULL
were	NULL
stained	NULL
with	NULL
anti-CD8	NULL
,	NULL
anti-TCR	NULL
,	NULL
and	NULL
anti-CD4	NULL
Abs	NULL
and	NULL
analyzed	NULL
on	NULL
a	NULL
FACScan	NULL
using	NULL
LYSIS	NULL
II	NULL
software	NULL
.	NULL

A	NULL
,	NULL
Typical	NULL
CD4/CD8	NULL
profiles	NULL
and	NULL
percentages	NULL
in	NULL
each	NULL
population	NULL
of	NULL
thymocytes	NULL
infected	NULL
with	NULL
10	NULL
``	NULL
pfu	NULL
of	NULL
virus	NULL
.	NULL

The	NULL
number	NULL
of	NULL
cells	NULL
per	NULL
lobe	NULL
for	NULL
each	NULL
quadrant	NULL
is	NULL
given	NULL
in	NULL
parentheses	NULL
.	NULL

B	NULL
,	NULL
Typical	NULL
CD4/CD	NULL
$	NULL
8	NULL
profiles	NULL
of	NULL
thymocytes	NULL
infected	NULL
with	NULL
10°	NULL
pfu	NULL
virus	NULL
.	NULL

C	NULL
,	NULL
Ratio	NULL
of	NULL
AdCMVmut-IxB-infected	NULL
thymocytes	NULL
to	NULL
AdCMVB-gal-infected	NULL
thymo-cytes	NULL
,	NULL
calculated	NULL
in	NULL
absolute	NULL
numbers	NULL
.	NULL

Each	NULL
dot	NULL
represents	NULL
a	NULL
separate	NULL
ex-periment	NULL
.	NULL

DN	NULL
,	NULL
double	NULL
negative	NULL
;	NULL
ISP	NULL
,	NULL
immature	NULL
,	NULL
TCR~	NULL
single	NULL
positive	NULL
;	NULL
DP	NULL
,	NULL
double	NULL
positive	NULL
;	NULL
SP	NULL
,	NULL
mature	NULL
,	NULL
TCR	NULL
*	NULL
single	NULL
positive	NULL
.	NULL

The	NULL
difference	NULL
between	NULL
AdCMVmut-IxB-infected	NULL
and	NULL
AdCMV	NULL
B-gal-infected	NULL
thymocytes	NULL
in	NULL
DP	NULL
and	NULL
SP	NULL
populations	NULL
is	NULL
highly	NULL
significant	NULL
(	NULL
p	NULL
<	NULL
0.0001	NULL
according	NULL
to	NULL
paired	NULL
Student	NULL
's	NULL
£	NULL
test	NULL
)	NULL
.	NULL

observed	NULL
among	NULL
the	NULL
CD4	NULL
*	NULL
SP	NULL
cells	NULL
.	NULL

The	NULL
total	NULL
CD8	NULL
*	NULL
SP	NULL
compartment	NULL
was	NULL
not	NULL
significantly	NULL
decreased	NULL
,	NULL
but	NULL
if	NULL
only	NULL
mature	NULL
CD8	NULL
*	NULL
SP	NULL
cells	NULL
are	NULL
considered	NULL
(	NULL
as	NULL
defined	NULL
by	NULL
high	NULL
levels	NULL
of	NULL
TCRB	NULL
expres-sion	NULL
)	NULL
,	NULL
a	NULL
significant	NULL
reduction	NULL
in	NULL
the	NULL
proportion	NULL
of	NULL
these	NULL
cells	NULL
was	NULL
observed	NULL
following	NULL
AdCMVmut-IkB	NULL
infection	NULL
.	NULL

As	NULL
the	NULL
total	NULL
number	NULL
of	NULL
thymocytes	NULL
in	NULL
AdCMVmut-I	NULL
«	NULL
B-infected	NULL
thymi	NULL
was	NULL
twofold	NULL
less	NULL
than	NULL
that	NULL
in	NULL
those	NULL
infected	NULL
with	NULL
AdCMV	NULL
B-gal	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
,	NULL
there	NULL
was	NULL
no	NULL
significant	NULL
difference	NULL
in	NULL
absolute	NULL
numbers	NULL
in	NULL
the	NULL
DN	NULL
population	NULL
,	NULL
while	NULL
the	NULL
reduction	NULL
in	NULL
the	NULL
DP	NULL
and	NULL
mature	NULL
SP	NULL
populations	NULL
was	NULL
highly	NULL
significant	NULL
(	NULL
p	NULL
<	NULL
0.0001	NULL
;	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
FTOC	NULL
from	NULL
IxBa	NULL
transgenic	NULL
mice	NULL
(	NULL
18	NULL
)	NULL
showed	NULL
a	NULL
similar	NULL
impairment	NULL
of	NULL
thymocyte	NULL
maturation	NULL
to	NULL
the	NULL
DP	NULL
stage	NULL
as	NULL
FTOC	NULL
infected	NULL
with	NULL
10	NULL
``	NULL
pfu	NULL
AdCMVmut-IkB	NULL
,	NULL
while	NULL
FTOCs	NULL
infected	NULL
with	NULL
10	NULL
``	NULL
or	NULL
10°	NULL
pfu	NULL
AdCMVB-gal	NULL
developed	NULL
in	NULL
a	NULL
similar	NULL
way	NULL
as	NULL
uninfected	NULL
FTOC	NULL
from	NULL
C57BL/6	NULL
mice	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

When	NULL
thymocytes	NULL
were	NULL
infected	NULL
with	NULL
10°	NULL
pfu	NULL
of	NULL
AdCMVmut-IxB	NULL
,	NULL
DP	NULL
and	NULL
SP	NULL
populations	NULL
were	NULL
virtually	NULL
absent	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

To	NULL
further	NULL
characterize	NULL
this	NULL
developmental	NULL
block	NULL
,	NULL
DN	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
anti-CD25	NULL
and	NULL
anti-CD44	NULL
Abs	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
CD8	NULL
CD44	NULL
FIGURE	NULL
3	NULL
.	NULL

Impairment	NULL
in	NULL
maturation	NULL
of	NULL
thymocytes	NULL
in	NULL
FTOCs	NULL
from	NULL
IxBa	NULL
transgenic	NULL
mice	NULL
.	NULL

Fetal	NULL
thymi	NULL
from	NULL
either	NULL
wild-type	NULL
(	NULL
WT	NULL
)	NULL
C57BL/6	NULL
or	NULL
IxBa	NULL
transgenic	NULL
mice	NULL
were	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
after	NULL
6	NULL
days	NULL
of	NULL
culture	NULL
.	NULL

CD4/CD	NULL
$	NULL
8	NULL
profiles	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
and	NULL
CD44/CD25	NULL
profiles	NULL
within	NULL
the	NULL
CD4~/CD8	NULL
~TCR~	NULL
population	NULL
(	NULL
Jower	NULL
panel	NULL
)	NULL
are	NULL
shown	NULL
.	NULL

we	NULL
observed	NULL
a	NULL
twofold	NULL
decrease	NULL
in	NULL
the	NULL
most	NULL
mature	NULL
,	NULL
CD44	NULL
DN	NULL
population	NULL
,	NULL
in	NULL
AdCMVmut-I	NULL
«	NULL
B-infected	NULL
thymic	NULL
lobes	NULL
relative	NULL
to	NULL
those	NULL
infected	NULL
with	NULL
AdCMVB-gal	NULL
.	NULL

This	NULL
decrease	NULL
is	NULL
paralleled	NULL
by	NULL
a	NULL
proportional	NULL
increase	NULL
in	NULL
the	NULL
CD44	NULL
-~CD25	NULL
*	NULL
population	NULL
that	NULL
directly	NULL
precedes	NULL
it	NULL
in	NULL
the	NULL
thymic	NULL
development	NULL
pathway	NULL
,	NULL
suggesting	NULL
a	NULL
developmental	NULL
block	NULL
at	NULL
the	NULL
stage	NULL
where	NULL
the	NULL
expression	NULL
of	NULL
CD25	NULL
is	NULL
down-regulated	NULL
.	NULL

TCRB	NULL
expression	NULL
and	NULL
proliferation	NULL
Since	NULL
the	NULL
developmental	NULL
block	NULL
we	NULL
observed	NULL
after	NULL
AdCMVmut-I	NULL
«	NULL
B	NULL
infection	NULL
occurs	NULL
at	NULL
the	NULL
same	NULL
stage	NULL
as	NULL
those	NULL
found	NULL
in	NULL
recombinase-activating	NULL
gene	NULL
(	NULL
RAG	NULL
)	NULL
'-	NULL
and	NULL
TCRB	NULL
'~	NULL
mice	NULL
,	NULL
which	NULL
are	NULL
both	NULL
unable	NULL
to	NULL
express	NULL
the	NULL
TCRB	NULL
gene	NULL
(	NULL
31-34	NULL
)	NULL
,	NULL
we	NULL
checked	NULL
whether	NULL
TCRB	NULL
was	NULL
normally	NULL
expressed	NULL
in	NULL
the	NULL
CD25	NULL
*CD44~	NULL
DN	NULL
population	NULL
.	NULL

Intracellular	NULL
staining	NULL
for	NULL
TCRPB	NULL
revealed	NULL
that	NULL
its	NULL
expression	NULL
was	NULL
not	NULL
decreased	NULL
in	NULL
AdCMVmut-IxB-infected	NULL
CD44	NULL
~CD25¢*	NULL
DN	NULL
thymocytes	NULL
;	NULL
68	NULL
+	NULL
3	NULL
%	NULL
stained	NULL
positive	NULL
for	NULL
intracellular	NULL
TCRB	NULL
compared	NULL
with	NULL
52	NULL
+	NULL
3	NULL
%	NULL
of	NULL
those	NULL
infected	NULL
with	NULL
AdCMVB-gal	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

To	NULL
check	NULL
whether	NULL
the	NULL
decreased	NULL
number	NULL
of	NULL
cells	NULL
in	NULL
the	NULL
CD25	NULL
CD44~	NULL
DN	NULL
population	NULL
was	NULL
due	NULL
to	NULL
a	NULL
lower	NULL
proliferation	NULL
rate	NULL
,	NULL
BrdU	NULL
was	NULL
added	NULL
to	NULL
the	NULL
FTOC	NULL
18	NULL
h	NULL
before	NULL
analysis	NULL
(	NULL
day	NULL
6	NULL
of	NULL
culture	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

6	NULL
shows	NULL
that	NULL
there	NULL
were	NULL
more	NULL
cells	NULL
of	NULL
the	NULL
mut-IxB	NULL
CD44	NULL
CD25	NULL
FIGURE	NULL
4	NULL
.	NULL

|	NULL
Impaired	NULL
transition	NULL
from	NULL
CD44~CD25¢	NULL
to	NULL
CD44	NULL
~CD25~	NULL
DN	NULL
thymocytes	NULL
.	NULL

Fetal	NULL
thymocytes	NULL
were	NULL
stained	NULL
with	NULL
anti-€CD44	NULL
,	NULL
anti-CD25	NULL
,	NULL
anti-CD4	NULL
,	NULL
anti-CD8	NULL
,	NULL
and	NULL
anti-TCR	NULL
Abs	NULL
.	NULL

Shown	NULL
are	NULL
CD44/CD25	NULL
profiles	NULL
within	NULL
the	NULL
CD4	NULL
CD8	NULL
TCR~	NULL
population	NULL
.	NULL

Contour	NULL
plots	NULL
are	NULL
representative	NULL
of	NULL
six	NULL
separate	NULL
experiments	NULL
yielding	NULL
similar	NULL
results	NULL
.	NULL

3459	NULL
A	NULL
cl	NULL
in	NULL
56	NULL
%	NULL
B-gal	NULL
2	NULL
C	NULL
®	NULL
>	NULL
W	NULL
mutixB	NULL
o	NULL
tez	NULL
arma	NULL
10	NULL
-	NULL
10	NULL
|	NULL
1¢C	NULL
-	NULL
10	NULL
_	NULL
10	NULL
icTCRaB	NULL
A	NULL
2	NULL
<	NULL
2	NULL
1	NULL
%	NULL
®	NULL
>	NULL
WL	NULL
l	NULL
To	NULL
10	NULL
19	NULL
-	NULL
id	NULL
hamster	NULL
IgG	NULL
FIGURE	NULL
5	NULL
.	NULL

Expression	NULL
of	NULL
intracellular	NULL
TCRaB	NULL
.	NULL

Fetal	NULL
thymocytes	NULL
were	NULL
stained	NULL
with	NULL
surface	NULL
Abs	NULL
anti-CD4	NULL
,	NULL
anti-CD8	NULL
,	NULL
anti-TCR	NULL
,	NULL
anti-CD44	NULL
,	NULL
and	NULL
anti-CD25	NULL
before	NULL
permeablizing	NULL
the	NULL
membrane	NULL
and	NULL
staining	NULL
intracellular	NULL
TCRB	NULL
.	NULL

Shown	NULL
are	NULL
intracellular	NULL
TCRB	NULL
levels	NULL
within	NULL
the	NULL
CD4	NULL
CD8~	NULL
CDA44-CD25*	NULL
surface	NULL
TCRB~-	NULL
population	NULL
.	NULL

As	NULL
a	NULL
specificity	NULL
control	NULL
,	NULL
the	NULL
same	NULL
population	NULL
was	NULL
stained	NULL
intracellularly	NULL
with	NULL
anti-hamster	NULL
IgG	NULL
.	NULL

AdCMVmut-IxB-infected	NULL
FTOC	NULL
proliferating	NULL
in	NULL
the	NULL
CD44	NULL
CD25	NULL
*	NULL
population	NULL
,	NULL
while	NULL
there	NULL
was	NULL
no	NULL
significant	NULL
difference	NULL
in	NULL
proliferation	NULL
rate	NULL
in	NULL
the	NULL
CD44-CD25~	NULL
population	NULL
.	NULL

These	NULL
data	NULL
were	NULL
confirmed	NULL
by	NULL
cell	NULL
cycle	NULL
analysis	NULL
using	NULL
propidium	NULL
iodide	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Apoptosis	NULL
Because	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
found	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
ensuring	NULL
the	NULL
survival	NULL
of	NULL
cells	NULL
(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
,	NULL
we	NULL
also	NULL
investigated	NULL
whether	NULL
AdCMVmut-IrB-infected	NULL
thymocytes	NULL
were	NULL
more	NULL
susceptible	NULL
to	NULL
apoptotic	NULL
death	NULL
than	NULL
AdCMVB-gal-infected	NULL
thymocytes	NULL
.	NULL

After	NULL
6	NULL
days	NULL
of	NULL
culture	NULL
thymocytes	NULL
were	NULL
stained	NULL
with	NULL
annexin	NULL
V	NULL
,	NULL
a	NULL
ligand	NULL
of	NULL
the	NULL
phosphatidylserine	NULL
that	NULL
is	NULL
expressed	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
apoptotic	NULL
cells	NULL
,	NULL
together	NULL
with	NULL
Abs	NULL
that	NULL
detect	NULL
surface	NULL
markers	NULL
.	NULL

Fig	NULL
.	NULL

8A	NULL
shows	NULL
that	NULL
there	NULL
was	NULL
a	NULL
significant	NULL
increase	NULL
in	NULL
apoptosis	NULL
,	NULL
as	NULL
measured	NULL
by	NULL
the	NULL
proportion	NULL
of	NULL
annexin	NULL
*	NULL
cells	NULL
,	NULL
in	NULL
the	NULL
CD44	NULL
-CD25~	NULL
DN	NULL
population	NULL
of	NULL
AdCMVmut-IxB-infected	NULL
cells	NULL
compared	NULL
with	NULL
that	NULL
in	NULL
the	NULL
population	NULL
of	NULL
AdCMV	NULL
B-gal-infected	NULL
cells	NULL
.	NULL

Apoptosis	NULL
in	NULL
the	NULL
CD44~-CD25¢	NULL
DN	NULL
population	NULL
was	NULL
also	NULL
increased	NULL
,	NULL
although	NULL
less	NULL
so	NULL
than	NULL
in	NULL
the	NULL
CD44	NULL
CD25	NULL
DN	NULL
population	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
using	NULL
the	NULL
TUNEL	NULL
method	NULL
(	NULL
37	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

The	NULL
higher	NULL
level	NULL
of	NULL
apoptosis-positive	NULL
cells	NULL
seen	NULL
in	NULL
the	NULL
TUNEL	NULL
assay	NULL
is	NULL
caused	NULL
by	NULL
a	NULL
longer	NULL
incubation	NULL
at	NULL
37°C	NULL
.	NULL

In	NULL
populations	NULL
containing	NULL
more	NULL
mature	NULL
thymocytes	NULL
(	NULL
DP	NULL
and	NULL
SP	NULL
)	NULL
,	NULL
no	NULL
significant	NULL
differences	NULL
in	NULL
levels	NULL
of	NULL
apoptosis	NULL
were	NULL
found	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
experiments	NULL
in	NULL
which	NULL
CD44	NULL
DN	NULL
cells	NULL
were	NULL
sorted	NULL
after	NULL
6	NULL
days	NULL
of	NULL
FTOC	NULL
and	NULL
subsequently	NULL
cultured	NULL
as	NULL
single	NULL
cells	NULL
at	NULL
37°C	NULL
for	NULL
18	NULL
h	NULL
,	NULL
only	NULL
2	NULL
%	NULL
of	NULL
the	NULL
sorted	NULL
cells	NULL
remained	NULL
alive	NULL
as	NULL
judged	NULL
by	NULL
uptake	NULL
of	NULL
trypan	NULL
blue	NULL
,	NULL
while	NULL
12	NULL
%	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
3460	NULL
A	NULL
B-gal	NULL
mutl	NULL
«	NULL
B	NULL
48	NULL
%	NULL
CD25+	NULL
o	NULL
10°	NULL
10	NULL
10°	NULL
10+	NULL
10	NULL
%	NULL
ou	NULL
is	NULL
Events	NULL
CD25	NULL
:	NULL
P3	NULL
Zz	NULL
ﬂ/ZZ	NULL
10°	NULL
10	NULL
10	NULL
10	NULL
10+	NULL
BrdU	NULL
Content	NULL
»	NULL
%	NULL
BrdU	NULL
+	NULL
B-gal	NULL
-	NULL
IxB	NULL
B-gal	NULL
_	NULL
IxB	NULL
CD25	NULL
FIGURE	NULL
6	NULL
.	NULL

AdCMVmut-IB-infected	NULL
thymocytes	NULL
have	NULL
no	NULL
proliferation	NULL
defect	NULL
.	NULL

Fetal	NULL
thymi	NULL
were	NULL
cultured	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

BrdU	NULL
was	NULL
added	NULL
to	NULL
the	NULL
culture	NULL
18	NULL
h	NULL
before	NULL
harvest	NULL
.	NULL

Thymocytes	NULL
were	NULL
stained	NULL
with	NULL
anti-CD8	NULL
,	NULL
anti-CD4	NULL
,	NULL
anti-TCR	NULL
,	NULL
anti-CD44	NULL
,	NULL
anti-€CD25	NULL
,	NULL
and	NULL
anti-BrdU	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
BrdU-positive	NULL
cells	NULL
was	NULL
measured	NULL
in	NULL
CD25*	NULL
or	NULL
CD25~	NULL
cells	NULL
by	NULL
flow	NULL
cytometry	NULL
after	NULL
electronically	NULL
gating	NULL
on	NULL
CD4	NULL
~CD8	NULL
TCR_CD44~	NULL
cells	NULL
.	NULL

B-gal	NULL
,	NULL
thymocytes	NULL
infected	NULL
with	NULL
AdCMVB-gal	NULL
;	NULL
IxB	NULL
,	NULL
thymocytes	NULL
infected	NULL
with	NULL
AdCMVmut-IxB	NULL
.	NULL

A	NULL
,	NULL
Typical	NULL
FACS	NULL
profiles	NULL
.	NULL

B	NULL
,	NULL
Differences	NULL
in	NULL
proliferation	NULL
between	NULL
control	NULL
and	NULL
AdCMVmut-IxB-infected	NULL
cells	NULL
.	NULL

Each	NULL
line	NULL
represents	NULL
data	NULL
from	NULL
a	NULL
separate	NULL
pool	NULL
.	NULL

CD25+	NULL
of	NULL
the	NULL
AdCMVB-gal	NULL
infected	NULL
cells	NULL
survived	NULL
.	NULL

As	NULL
CD44-CD25*	NULL
cells	NULL
are	NULL
known	NULL
to	NULL
down-regulate	NULL
CD25	NULL
within	NULL
this	NULL
time	NULL
frame	NULL
,	NULL
these	NULL
data	NULL
support	NULL
the	NULL
results	NULL
obtained	NULL
with	NULL
the	NULL
annexin	NULL
and	NULL
TUNEL	NULL
assays	NULL
.	NULL

Discussion	NULL
Many	NULL
insights	NULL
into	NULL
thymocyte	NULL
development	NULL
have	NULL
been	NULL
obtained	NULL
using	NULL
gene-defective	NULL
and	NULL
transgenic	NULL
mice	NULL
(	NULL
8	NULL
,	NULL
38	NULL
)	NULL
.	NULL

Here	NULL
we	NULL
report	NULL
a	NULL
novel	NULL
technique	NULL
in	NULL
which	NULL
we	NULL
use	NULL
an	NULL
adenoviral	NULL
vector	NULL
to	NULL
introduce	NULL
and	NULL
express	NULL
genes	NULL
in	NULL
developing	NULL
fetal	NULL
thymocytes	NULL
.	NULL

Earlier	NULL
reports	NULL
as	NULL
well	NULL
as	NULL
our	NULL
own	NULL
unpublished	NULL
results	NULL
indicated	NULL
that	NULL
adult	NULL
thymocytes	NULL
and	NULL
T	NULL
cells	NULL
were	NULL
infected	NULL
with	NULL
low	NULL
efficiency	NULL
by	NULL
adenovirus	NULL
(	NULL
39	NULL
)	NULL
.	NULL

We	NULL
show	NULL
that	NULL
at	NULL
a	NULL
multiplicity	NULL
of	NULL
infection	NULL
that	NULL
does	NULL
not	NULL
interfere	NULL
with	NULL
normal	NULL
development	NULL
,	NULL
most	NULL
thymocytes	NULL
can	NULL
be	NULL
infected	NULL
with	NULL
recombinant	NULL
adenovirus	NULL
in	NULL
FTOC	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
ret-roviruses	NULL
,	NULL
adenovirus	NULL
does	NULL
not	NULL
require	NULL
cell	NULL
division	NULL
and	NULL
can	NULL
be	NULL
easily	NULL
obtained	NULL
in	NULL
high	NULL
titers	NULL
.	NULL

Furthermore	NULL
,	NULL
no	NULL
coculture	NULL
with	NULL
packaging	NULL
cells	NULL
is	NULL
necessary	NULL
(	NULL
40	NULL
,	NULL
41	NULL
)	NULL
.	NULL

This	NULL
system	NULL
could	NULL
thus	NULL
become	NULL
an	NULL
extremely	NULL
useful	NULL
tool	NULL
to	NULL
study	NULL
the	NULL
roles	NULL
of	NULL
the	NULL
various	NULL
genes	NULL
expressed	NULL
during	NULL
thymocyte	NULL
development	NULL
.	NULL

Because	NULL
we	NULL
use	NULL
a	NULL
CMV	NULL
promoter	NULL
we	NULL
can	NULL
not	NULL
formally	NULL
exclude	NULL
that	NULL
the	NULL
effects	NULL
we	NULL
saw	NULL
were	NULL
NEF-	NULL
«	NULL
B	NULL
IN	NULL
FETAL	NULL
THYMOCYTE	NULL
DEVELOPMENT	NULL
&	NULL
$	NULL
.	NULL

4	NULL
w	NULL
3	NULL
°	NULL
u	NULL
FL2-Width	NULL
__	NULL
**	NULL
©D44*CD25®	NULL
CD44CD25+	NULL
CD44CD25	NULL
C	NULL
i	NULL
151	NULL
%	NULL
,	NULL
C	NULL
21	NULL
%	NULL
muthcB	NULL
l	NULL
-=-2-	NULL
&	NULL
€	NULL
®	NULL
>	NULL
)	NULL
of	NULL
a	NULL
or	NULL
al	NULL
3	NULL
5	NULL
a	NULL
11	NULL
%	NULL
35	NULL
%	NULL
27	NULL
%	NULL
i	NULL
--	NULL
--	NULL
-	NULL
i	NULL
--	NULL
_	NULL
--	NULL
i	NULL
(	NULL
-gal	NULL
i	NULL
--	NULL
--	NULL
4	NULL
L	NULL
DNA	NULL
content	NULL
FIGURE	NULL
7	NULL
.	NULL

Cell	NULL
cycle	NULL
analysis	NULL
of	NULL
the	NULL
DN	NULL
population	NULL
.	NULL

Different	NULL
populations	NULL
within	NULL
the	NULL
DN	NULL
compartment	NULL
were	NULL
sorted	NULL
by	NULL
FACS	NULL
.	NULL

Then	NULL
cells	NULL
were	NULL
permeablized	NULL
,	NULL
and	NULL
DNA	NULL
was	NULL
stained	NULL
by	NULL
propidium	NULL
iodide	NULL
.	NULL

due	NULL
to	NULL
infection	NULL
of	NULL
stromal	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
FTOC	NULL
from	NULL
transgenic	NULL
mice	NULL
with	NULL
IxBa	NULL
expression	NULL
targeted	NULL
to	NULL
lymphoid	NULL
lineage	NULL
cells	NULL
showed	NULL
maturational	NULL
defects	NULL
very	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
wild-type	NULL
A	NULL
CD25+	NULL
CD25	NULL
Boa	NULL
|_	NULL
f\	NULL
-*-	NULL
10	NULL
o	NULL
1¢	NULL
1¢	NULL
10	NULL
0	NULL
%	NULL
F	NULL
--	NULL
-	NULL
1¢	NULL
-	NULL
10	NULL
``	NULL
1¢	NULL
10	NULL
10+	NULL
Annexin	NULL
V	NULL
B	NULL
CD25+	NULL
CD25	NULL
:	NULL
3	NULL
3	NULL
B-gal	NULL
11	NULL
%	NULL
F	NULL
-a	NULL
9	NULL
|	NULL
inf	NULL
10	NULL
ir	NULL
10	NULL
d	NULL
|g	NULL
mutikB	NULL
©	NULL
io	NULL
``	NULL
102	NULL
“	NULL
10	NULL
10	NULL
TUNEL	NULL
FIGURE	NULL
8	NULL
.	NULL

Increased	NULL
susceptibility	NULL
to	NULL
apoptosis	NULL
of	NULL
AdCMVmut-I	NULL
«	NULL
B-infected	NULL
thymocytes	NULL
.	NULL

A	NULL
,	NULL
Single-cell	NULL
suspensions	NULL
from	NULL
FTOC	NULL
were	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
1	NULL
h	NULL
and	NULL
stained	NULL
with	NULL
anti-CD8	NULL
,	NULL
anti-CD4	NULL
,	NULL
anti-TCR	NULL
,	NULL
anti-CD44	NULL
,	NULL
anti-CD25	NULL
,	NULL
and	NULL
annexin	NULL
V.	NULL
Annexin	NULL
V	NULL
profiles	NULL
within	NULL
the	NULL
CD4~CD8-TCR~-CD44-CD25¢*	NULL
and	NULL
CD4~CD8~-TCR-CD44-CD25~	NULL
populations	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
data	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

B	NULL
,	NULL
Single-cell	NULL
suspensions	NULL
from	NULL
FTOC	NULL
were	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
3	NULL
h.	NULL
After	NULL
staining	NULL
the	NULL
surface	NULL
with	NULL
anti-CD8	NULL
,	NULL
anti-CD4	NULL
,	NULL
anti-TCR	NULL
,	NULL
anti-CD44	NULL
,	NULL
and	NULL
anti-CD25	NULL
,	NULL
cells	NULL
were	NULL
permeablized	NULL
,	NULL
and	NULL
DNA	NULL
strand	NULL
breaks	NULL
were	NULL
labeled	NULL
with	NULL
BrdU	NULL
.	NULL

TUNEL	NULL
profiles	NULL
within	NULL
the	NULL
CD4~CD8~-TCR~-CD44~CD25*	NULL
and	NULL
CD4-CD8~-TCR~CD44-CD25~	NULL
populations	NULL
are	NULL
shown	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
thymocytes	NULL
infected	NULL
with	NULL
AdCMVmut-I	NULL
«	NULL
B	NULL
.	NULL

This	NULL
strongly	NULL
suggests	NULL
that	NULL
the	NULL
observed	NULL
effects	NULL
are	NULL
intrinsic	NULL
to	NULL
the	NULL
thymocytes	NULL
and	NULL
are	NULL
not	NULL
due	NULL
to	NULL
an	NULL
effect	NULL
in	NULL
trans	NULL
of	NULL
the	NULL
stromal	NULL
cells	NULL
.	NULL

Our	NULL
system	NULL
makes	NULL
it	NULL
possible	NULL
to	NULL
pinpoint	NULL
the	NULL
exact	NULL
stage	NULL
in	NULL
fetal	NULL
development	NULL
at	NULL
which	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
involved	NULL
,	NULL
since	NULL
such	NULL
critical	NULL
parameters	NULL
as	NULL
the	NULL
time	NULL
in	NULL
development	NULL
at	NULL
which	NULL
NF-KB	NULL
is	NULL
inhibited	NULL
can	NULL
be	NULL
rigorously	NULL
con-trolled	NULL
,	NULL
and	NULL
thymocyte	NULL
development	NULL
can	NULL
be	NULL
studied	NULL
in	NULL
isolation	NULL
of	NULL
other	NULL
organs	NULL
.	NULL

As	NULL
a	NULL
result	NULL
of	NULL
NF-KB	NULL
inhibition	NULL
,	NULL
we	NULL
observed	NULL
a	NULL
partial	NULL
block	NULL
in	NULL
the	NULL
maturation	NULL
of	NULL
CD4	NULL
-	NULL
CD8~	NULL
DN	NULL
thymocytes	NULL
between	NULL
the	NULL
CD44-CD25¢	NULL
and	NULL
CD44~-CD25~	NULL
stages	NULL
.	NULL

A	NULL
complete	NULL
block	NULL
at	NULL
this	NULL
stage	NULL
was	NULL
also	NULL
observed	NULL
in	NULL
RAG	NULL
and	NULL
TCRB	NULL
knockout	NULL
mice	NULL
(	NULL
31-34	NULL
)	NULL
.	NULL

In	NULL
both	NULL
,	NULL
the	NULL
TCR	NULL
B-chain	NULL
can	NULL
not	NULL
be	NULL
rearranged	NULL
,	NULL
and	NULL
cells	NULL
therefore	NULL
do	NULL
not	NULL
enter	NULL
the	NULL
cell	NULL
cycle	NULL
due	NULL
to	NULL
the	NULL
inability	NULL
to	NULL
form	NULL
a	NULL
pre-TCR	NULL
complex	NULL
.	NULL

In	NULL
either	NULL
of	NULL
these	NULL
mouse	NULL
strains	NULL
,	NULL
cross-linking	NULL
of	NULL
CD3e	NULL
results	NULL
in	NULL
proliferation	NULL
and	NULL
transition	NULL
to	NULL
the	NULL
DP	NULL
stage	NULL
(	NULL
42	NULL
,	NULL
43	NULL
)	NULL
.	NULL

In	NULL
thymocytes	NULL
infected	NULL
with	NULL
AdCMVmut-IrB	NULL
we	NULL
have	NULL
rescued	NULL
maturation	NULL
at	NULL
the	NULL
CD44	NULL
-~CD25	NULL
*	NULL
stage	NULL
in	NULL
a	NULL
similar	NULL
manner	NULL
by	NULL
cross-linking	NULL
CD3e	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
our	NULL
system	NULL
,	NULL
however	NULL
,	NULL
TCRB	NULL
expression	NULL
appeared	NULL
to	NULL
occur	NULL
normally	NULL
.	NULL

Indeed	NULL
,	NULL
a	NULL
slightly	NULL
higher	NULL
percentage	NULL
of	NULL
cells	NULL
at	NULL
the	NULL
CD44	NULL
-CD25¢~	NULL
DN	NULL
stage	NULL
expressed	NULL
intracellular	NULL
TCR	NULL
#	NULL
B	NULL
protein	NULL
in	NULL
the	NULL
AdCMVmut-IB-infected	NULL
thymocytes	NULL
compared	NULL
with	NULL
the	NULL
AdCMV	NULL
B-gal-infected	NULL
thy-mocytes	NULL
,	NULL
implying	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
not	NULL
necessary	NULL
for	NULL
expression	NULL
of	NULL
TCRB	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
percentage	NULL
of	NULL
cycling	NULL
cells	NULL
in	NULL
the	NULL
CD44	NULL
-CD25¢	NULL
DN	NULL
subset	NULL
was	NULL
similar	NULL
in	NULL
AdCMVmut-IxB-infected	NULL
thymocytes	NULL
to	NULL
that	NULL
observed	NULL
in	NULL
AdCMV	NULL
B-gal-infected	NULL
thy-mocytes	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
pre-TCR	NULL
complex	NULL
is	NULL
functional	NULL
.	NULL

Since	NULL
NF-KB	NULL
family	NULL
members	NULL
are	NULL
differentially	NULL
expressed	NULL
in	NULL
the	NULL
cortical	NULL
and	NULL
medullary	NULL
compartments	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
NF-KB	NULL
has	NULL
more	NULL
than	NULL
one	NULL
function	NULL
in	NULL
thymocyte	NULL
development	NULL
.	NULL

Our	NULL
results	NULL
could	NULL
be	NULL
interpreted	NULL
as	NULL
the	NULL
consequence	NULL
of	NULL
two	NULL
concurrent	NULL
effects	NULL
:	NULL
first	NULL
,	NULL
a	NULL
delayed	NULL
down-regulation	NULL
of	NULL
CD25	NULL
,	NULL
and	NULL
second	NULL
,	NULL
a	NULL
massive	NULL
apoptosis	NULL
in	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
also	NULL
likely	NULL
that	NULL
the	NULL
function	NULL
of	NULL
NF-KB	NULL
in	NULL
thymocyte	NULL
development	NULL
is	NULL
not	NULL
identical	NULL
in	NULL
adults	NULL
or	NULL
fetuses	NULL
,	NULL
as	NULL
maturation	NULL
pathways	NULL
in	NULL
these	NULL
two	NULL
life	NULL
stages	NULL
are	NULL
known	NULL
to	NULL
differ	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Multiple	NULL
functions	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
could	NULL
explain	NULL
the	NULL
differences	NULL
between	NULL
the	NULL
maturation	NULL
defects	NULL
observed	NULL
in	NULL
adult	NULL
IxBa	NULL
transgenic	NULL
mice	NULL
,	NULL
on	NULL
the	NULL
one	NULL
hand	NULL
,	NULL
and	NULL
in	NULL
FTOC	NULL
from	NULL
the	NULL
same	NULL
transgenic	NULL
mice	NULL
or	NULL
from	NULL
normal	NULL
mice	NULL
infected	NULL
with	NULL
AdCMVmut-IB	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
.	NULL

In	NULL
the	NULL
first	NULL
case	NULL
,	NULL
cells	NULL
develop	NULL
normally	NULL
until	NULL
the	NULL
DP	NULL
stage	NULL
(	NULL
18	NULL
)	NULL
,	NULL
whereas	NULL
in	NULL
the	NULL
other	NULL
two	NULL
cases	NULL
perturbation	NULL
of	NULL
maturation	NULL
starts	NULL
at	NULL
earlier	NULL
stages	NULL
.	NULL

Earlier	NULL
studies	NULL
indicate	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
regulating	NULL
apoptosis	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
.	NULL

In	NULL
RelA	NULL
knockout	NULL
em-bryos	NULL
,	NULL
hepatocytes	NULL
undergo	NULL
massive	NULL
apoptosis	NULL
on	NULL
day	NULL
15	NULL
of	NULL
gestation	NULL
,	NULL
and	NULL
RelA-deficient	NULL
fibroblasts	NULL
and	NULL
macrophages	NULL
are	NULL
more	NULL
sensitive	NULL
to	NULL
killing	NULL
by	NULL
TNF	NULL
(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
.	NULL

It	NULL
has	NULL
also	NULL
been	NULL
suggested	NULL
that	NULL
Rel-related	NULL
proteins	NULL
protect	NULL
B	NULL
lymphocytes	NULL
from	NULL
apoptosis	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Boothby	NULL
et	NULL
al	NULL
.	NULL

found	NULL
that	NULL
primary	NULL
T	NULL
cells	NULL
expressing	NULL
a	NULL
mutant	NULL
IxBa	NULL
are	NULL
more	NULL
susceptible	NULL
to	NULL
apoptosis	NULL
induced	NULL
by	NULL
stimulation	NULL
through	NULL
the	NULL
TCR	NULL
,	NULL
which	NULL
suggests	NULL
a	NULL
protective	NULL
role	NULL
for	NULL
NF-KB	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Here	NULL
we	NULL
show	NULL
that	NULL
CD44	NULL
DN	NULL
thymocytes	NULL
infected	NULL
with	NULL
AdCMVmut-IrB	NULL
are	NULL
more	NULL
susceptible	NULL
to	NULL
apoptosis	NULL
than	NULL
those	NULL
infected	NULL
with	NULL
AdCMV	NULL
B-gal	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
protecting	NULL
thymocytes	NULL
from	NULL
undergoing	NULL
apoptosis	NULL
in	NULL
early	NULL
stages	NULL
of	NULL
development	NULL
.	NULL

It	NULL
is	NULL
not	NULL
yet	NULL
clear	NULL
whether	NULL
the	NULL
antiapoptotic	NULL
functions	NULL
of	NULL
NF-KB	NULL
also	NULL
involve	NULL
extracellular	NULL
pathways	NULL
.	NULL

Transferred	NULL
into	NULL
normal	NULL
mice	NULL
,	NULL
fetal	NULL
liver	NULL
cells	NULL
deficient	NULL
for	NULL
NF-	NULL
«	NULL
B1/p50	NULL
and	NULL
RelA	NULL
were	NULL
did	NULL
not	NULL
undergo	NULL
any	NULL
T	NULL
cell	NULL
development	NULL
.	NULL

However	NULL
,	NULL
when	NULL
doubly	NULL
deficient	NULL
fetal	NULL
liver	NULL
cells	NULL
were	NULL
mixed	NULL
with	NULL
normal	NULL
fetal	NULL
liver	NULL
cells	NULL
,	NULL
both	NULL
the	NULL
normal	NULL
liver	NULL
cells	NULL
and	NULL
the	NULL
deficient	NULL
liver	NULL
cells	NULL
developed	NULL
normally	NULL
(	NULL
45	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
NF-KB	NULL
can	NULL
influence	NULL
thymocyte	NULL
development	NULL
by	NULL
means	NULL
of	NULL
an	NULL
extracellular	NULL
fac-	NULL
3461	NULL
tor	NULL
.	NULL

Furthermore	NULL
,	NULL
many	NULL
cytokines	NULL
are	NULL
known	NULL
to	NULL
be	NULL
regulated	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
46	NULL
)	NULL
,	NULL
while	NULL
other	NULL
studies	NULL
show	NULL
that	NULL
defined	NULL
cytokines	NULL
are	NULL
required	NULL
for	NULL
proliferation	NULL
and	NULL
development	NULL
at	NULL
different	NULL
stages	NULL
of	NULL
thymocyte	NULL
development	NULL
(	NULL
47	NULL
,	NULL
48	NULL
)	NULL
.	NULL

It	NULL
thus	NULL
seems	NULL
reasonable	NULL
to	NULL
speculate	NULL
that	NULL
NF-	NULL
«	NULL
B-regulated	NULL
cytokines	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
ensuring	NULL
the	NULL
survival	NULL
of	NULL
early	NULL
thymocytes	NULL
.	NULL

Besides	NULL
cytokines	NULL
,	NULL
it	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
other	NULL
intra-	NULL
or	NULL
extracellular	NULL
factors	NULL
are	NULL
involved	NULL
.	NULL

Bel-2	NULL
,	NULL
for	NULL
example	NULL
,	NULL
is	NULL
known	NULL
to	NULL
be	NULL
highly	NULL
expressed	NULL
in	NULL
CD44	NULL
-CD25	NULL
*	NULL
thymocytes	NULL
and	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
protect	NULL
different	NULL
cell	NULL
types	NULL
from	NULL
undergoing	NULL
apoptosis	NULL
(	NULL
49	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
our	NULL
data	NULL
indicate	NULL
that	NULL
if	NULL
NF-KB	NULL
is	NULL
kept	NULL
inactive	NULL
during	NULL
early	NULL
fetal	NULL
thymocyte	NULL
development	NULL
,	NULL
cells	NULL
develop	NULL
normally	NULL
until	NULL
the	NULL
CD44	NULL
-CD25	NULL
¢	NULL
DN	NULL
stage	NULL
.	NULL

At	NULL
this	NULL
stage	NULL
,	NULL
activation	NULL
of	NULL
NF-KB	NULL
is	NULL
required	NULL
to	NULL
convey	NULL
a	NULL
signal	NULL
without	NULL
which	NULL
the	NULL
cells	NULL
will	NULL
fail	NULL
to	NULL
develop	NULL
further	NULL
and	NULL
will	NULL
eventually	NULL
die	NULL
by	NULL
apoptosis	NULL
.	NULL

Whether	NULL
this	NULL
signal	NULL
induces	NULL
the	NULL
production	NULL
of	NULL
intrinsic	NULL
or	NULL
extrinsic	NULL
factors	NULL
remains	NULL
to	NULL
be	NULL
resolved	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
we	NULL
have	NULL
established	NULL
a	NULL
novel	NULL
infection	NULL
system	NULL
to	NULL
express	NULL
relevant	NULL
genes	NULL
in	NULL
FTOC	NULL
,	NULL
allowing	NULL
a	NULL
detailed	NULL
dissection	NULL
of	NULL
the	NULL
complex	NULL
molecular	NULL
and	NULL
cellular	NULL
interactions	NULL
implicated	NULL
in	NULL
thymic	NULL
development	NULL
.	NULL

We	NULL
were	NULL
able	NULL
to	NULL
precisely	NULL
describe	NULL
thymic	NULL
maturation	NULL
defects	NULL
that	NULL
occur	NULL
when	NULL
NF-KB	NULL
is	NULL
inactivated	NULL
from	NULL
day	NULL
14	NULL
of	NULL
gestation	NULL
.	NULL

We	NULL
are	NULL
currently	NULL
in	NULL
the	NULL
process	NULL
of	NULL
generating	NULL
new	NULL
adenoviral	NULL
constructs	NULL
to	NULL
study	NULL
the	NULL
role	NULL
of	NULL
other	NULL
genes	NULL
of	NULL
potential	NULL
importance	NULL
in	NULL
lymphocyte	NULL
development	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Pierre	NULL
Zaech	NULL
for	NULL
expert	NULL
assistance	NULL
with	NULL
the	NULL
FACS	NULL
,	NULL
Darryl	NULL
Reed	NULL
for	NULL
providing	NULL
adenoviral	NULL
constructs	NULL
,	NULL
Christoph	NULL
Esslinger	NULL
for	NULL
providing	NULL
IxBa	NULL
transgenic	NULL
mice	NULL
,	NULL
and	NULL
Anne	NULL
Wilson	NULL
,	NULL
Myriam	NULL
Capone	NULL
,	NULL
and	NULL
H.	NULL
Robson	NULL
MacDonald	NULL
for	NULL
discussion	NULL
and	NULL
critical	NULL
comments	NULL
on	NULL
the	NULL
manuscript	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Levelt	NULL
,	NULL
C.	NULL
N.	NULL
,	NULL
and	NULL
K.	NULL
Eichmann	NULL
.	NULL

1995	NULL
.	NULL

Receptors	NULL
and	NULL
signals	NULL
in	NULL
early	NULL
thymic	NULL
selection	NULL
.	NULL

Immunity	NULL
3:667	NULL
.	NULL

2	NULL
.	NULL

Kisiclow	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
A.	NULL
Miazck	NULL
.	NULL

1995	NULL
.	NULL

Positive	NULL
selection	NULL
of	NULL
T	NULL
cells	NULL
:	NULL
rescue	NULL
from	NULL
programmed	NULL
cell	NULL
death	NULL
and	NULL
differentiation	NULL
require	NULL
continual	NULL
engagement	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181:1975	NULL
.	NULL

3	NULL
.	NULL

Shortman	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
L.	NULL
Wu	NULL
.	NULL

1996	NULL
.	NULL

Early	NULL
T	NULL
lymphocyte	NULL
progenitors	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14:29	NULL
.	NULL

4	NULL
.	NULL

Godfrey	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
and	NULL
A.	NULL
Zlotnik	NULL
.	NULL

1993	NULL
.	NULL

Control	NULL
points	NULL
in	NULL
early	NULL
T-cell	NULL
development	NULL
.	NULL

Immunol	NULL
Today	NULL
14:547	NULL
.	NULL

5	NULL
.	NULL

Godfrey	NULL
,	NULL
D.	NULL
I.	NULL
,	NULL
J.	NULL
Kennedy	NULL
,	NULL
P.	NULL
Mombaerts	NULL
,	NULL
S.	NULL
Tonegawa	NULL
,	NULL
and	NULL
A.	NULL
Zlotnik	NULL
.	NULL

1994	NULL
.	NULL

Onset	NULL
of	NULL
TCR-B	NULL
gene	NULL
rearrangement	NULL
and	NULL
role	NULL
of	NULL
TCR-B	NULL
expression	NULL
during	NULL
CD3	NULL
~CD4_CD8~	NULL
thymocyte	NULL
differentiation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

152:4783	NULL
.	NULL

6	NULL
.	NULL

Tourigny	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
S.	NULL
Mazel	NULL
,	NULL
D.	NULL
B.	NULL
Burtrum	NULL
,	NULL
and	NULL
H.	NULL
T.	NULL
Petrie	NULL
.	NULL

1997	NULL
.	NULL

T	NULL
cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
-B	NULL
gene	NULL
recombination	NULL
:	NULL
dissociation	NULL
from	NULL
cell	NULL
cycle	NULL
regulation	NULL
and	NULL
developmental	NULL
progression	NULL
during	NULL
T	NULL
cell	NULL
ontogeny	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185:1549	NULL
.	NULL

7.	NULL
von	NULL
Bochmer	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
H.	NULL
J.	NULL
Fehling	NULL
.	NULL

1997	NULL
.	NULL

Structure	NULL
and	NULL
function	NULL
of	NULL
the	NULL
pre-T	NULL
cell	NULL
receptor	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

15:433	NULL
.	NULL

8	NULL
.	NULL

Kisiclow	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
H.	NULL
von	NULL
Bochmer	NULL
.	NULL

1995	NULL
.	NULL

Development	NULL
and	NULL
selection	NULL
of	NULL
T	NULL
cells	NULL
:	NULL
facts	NULL
and	NULL
puzzles	NULL
.	NULL

Adv	NULL
.	NULL

Immunol	NULL
.	NULL

58:87	NULL
.	NULL

9	NULL
.	NULL

Robey	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
B.	NULL
J.	NULL
Fowlkes	NULL
.	NULL

1994	NULL
.	NULL

Selective	NULL
events	NULL
in	NULL
T	NULL
cell	NULL
development	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:675	NULL
.	NULL

10	NULL
.	NULL

Haskill	NULL
,	NULL
S.	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
Beg	NULL
,	NULL
S.	NULL
M.	NULL
Tompkins	NULL
,	NULL
J.	NULL
S.	NULL
Morris	NULL
,	NULL
A.	NULL
D.	NULL
Yurochko	NULL
,	NULL
A.	NULL
Sampson-Johannes	NULL
,	NULL
K.	NULL
Mondal	NULL
,	NULL
P.	NULL
Ralph	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1991	NULL
.	NULL

Characterization	NULL
of	NULL
an	NULL
immediate-early	NULL
gene	NULL
induced	NULL
in	NULL
adherent	NULL
monocytes	NULL
that	NULL
encodes	NULL
IxB-like	NULL
activity	NULL
.	NULL

Cell	NULL
65:1281	NULL
.	NULL

11	NULL
.	NULL

Henkel	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Machleidt	NULL
,	NULL
I	NULL
Alkalay	NULL
,	NULL
M.	NULL
Kronke	NULL
,	NULL
Y.	NULL
Ben-Neriah	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Bacuerle	NULL
.	NULL

1993	NULL
.	NULL

Rapid	NULL
proteolysis	NULL
of	NULL
IxBa	NULL
is	NULL
necessary	NULL
for	NULL
activation	NULL
of	NULL
transcription	NULL
factor	NULL
NF-kB	NULL
.	NULL

Nature	NULL
365:182	NULL
.	NULL

12	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
M.	NULL
Lenardo	NULL
,	NULL
J.	NULL
W.	NULL
Pierce	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

Phorbol-ester-induced	NULL
activation	NULL
of	NULL
the	NULL
NF-KB	NULL
transcription	NULL
factor	NULL
involves	NULL
dissociation	NULL
of	NULL
an	NULL
apparently	NULL
cytoplasmic	NULL
NF-B/inhibitor	NULL
complex	NULL
.	NULL

Cold	NULL
Spring	NULL
Harb	NULL
.	NULL

Symp	NULL
.	NULL

Quant	NULL
.	NULL

Biol	NULL
.	NULL

53:789	NULL
.	NULL

13	NULL
.	NULL

Ivanov	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
R.	NULL
Ceredig	NULL
.	NULL

1992	NULL
.	NULL

Transcription	NULL
factors	NULL
in	NULL
mouse	NULL
fetal	NULL
thymus	NULL
development	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

4:729	NULL
.	NULL

14	NULL
.	NULL

Weih	NULL
,	NULL
F.	NULL
,	NULL
D.	NULL
Carrasco	NULL
,	NULL
and	NULL
R.	NULL
Bravo	NULL
.	NULL

1994	NULL
.	NULL

Constitutive	NULL
and	NULL
inducible	NULL
Re/NF-KB	NULL
activities	NULL
in	NULL
mouse	NULL
thymus	NULL
and	NULL
spleen	NULL
.	NULL

Oncogene	NULL
9:3289	NULL
.	NULL

15	NULL
.	NULL

Sen	NULL
,	NULL
J.	NULL
,	NULL
L.	NULL
Venkataraman	NULL
,	NULL
Y.	NULL
Shinkai	NULL
,	NULL
J.	NULL
W.	NULL
Pierce	NULL
,	NULL
F.	NULL
W.	NULL
Alt	NULL
,	NULL
S.	NULL
J.	NULL
Burakoff	NULL
,	NULL
and	NULL
R.	NULL
Sen.	NULL
1995	NULL
.	NULL

Expression	NULL
and	NULL
induction	NULL
of	NULL
nuclear	NULL
proteins	NULL
in	NULL
thymocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154:3213	NULL
.	NULL

16	NULL
.	NULL

Tan	NULL
,	NULL
T.	NULL
H.	NULL
,	NULL
G.	NULL
P.	NULL
Huang	NULL
,	NULL
A.	NULL
Sica	NULL
,	NULL
P.	NULL
Ghosh	NULL
,	NULL
H.	NULL
A	NULL
.	NULL

Young	NULL
,	NULL
D.	NULL
L.	NULL
Longo	NULL
,	NULL
and	NULL
N.	NULL
R.	NULL
Rice	NULL
.	NULL

1992	NULL
.	NULL

«	NULL
B	NULL
site-dependent	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
a-chain	NULL
gene	NULL
promoter	NULL
by	NULL
human	NULL
c-Rel	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:4067	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
3462	NULL
17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

Garoufalis	NULL
,	NULL
E.	NULL
,	NULL
I.	NULL
Kwan	NULL
,	NULL
R.	NULL
Lin	NULL
,	NULL
A.	NULL
Mustafa	NULL
,	NULL
N.	NULL
Pepin	NULL
,	NULL
A.	NULL
Roulston	NULL
,	NULL
J.	NULL
Lacoste	NULL
,	NULL
and	NULL
J.	NULL
Hiscott	NULL
.	NULL

1994	NULL
.	NULL

Viral	NULL
induction	NULL
of	NULL
the	NULL
human	NULL
f	NULL
interferon	NULL
promoter	NULL
:	NULL
modulation	NULL
of	NULL
transcription	NULL
by	NULL
NF-B/Re	NULL
!	NULL

proteins	NULL
and	NULL
interferon	NULL
regulatory	NULL
factors	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:4707	NULL
.	NULL

Esslinger	NULL
,	NULL
C.	NULL
W.	NULL
,	NULL
A.	NULL
Wilson	NULL
,	NULL
B.	NULL
Sordat	NULL
,	NULL
F.	NULL
Beermann	NULL
,	NULL
and	NULL
C.	NULL
V.	NULL
Jongeneel	NULL
.	NULL

1997	NULL
.	NULL

Abnormal	NULL
T	NULL
lymphocyte	NULL
development	NULL
induced	NULL
by	NULL
targeted	NULL
overexpression	NULL
of	NULL
IkBa	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

158:5075	NULL
.	NULL

Boothby	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
A.	NULL
L.	NULL
Mora	NULL
,	NULL
D.	NULL
C.	NULL
Scherer	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Brockman	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Ballard	NULL
.	NULL

1997	NULL
.	NULL

Perturbation	NULL
of	NULL
the	NULL
T	NULL
lymphocyte	NULL
lineage	NULL
in	NULL
transgenic	NULL
mice	NULL
expressing	NULL
a	NULL
constitutive	NULL
repressor	NULL
of	NULL
nuclear	NULL
factor	NULL
(	NULL
NF	NULL
)	NULL
-KB	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185:1897	NULL
.	NULL

Brown	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Gerstberger	NULL
,	NULL
L.	NULL
Carlson	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
U.	NULL
Sicbenlist	NULL
.	NULL

1995	NULL
.	NULL

Control	NULL
of	NULL
IkBa	NULL
proteolysis	NULL
by	NULL
site-specific	NULL
,	NULL
signal-induced	NULL
phosphorylation	NULL
.	NULL

Science	NULL
267:1485	NULL
.	NULL

Reed	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
P.	NULL
Romero	NULL
,	NULL
D.	NULL
Rimoldi	NULL
,	NULL
J.	NULL
C.	NULL
Cerottini	NULL
,	NULL
J.	NULL
Schaack	NULL
,	NULL
and	NULL
C.	NULL
V.	NULL
Jongeneel	NULL
.	NULL

1997	NULL
.	NULL

Construction	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
recombinant	NULL
adenovirus	NULL
directing	NULL
expression	NULL
of	NULL
the	NULL
MAGE-1	NULL
tumor-specific	NULL
antigen	NULL
.	NULL

Inf	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
72:1045	NULL
.	NULL

Bakker	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
D.	NULL
Reed	NULL
,	NULL
T.	NULL
Renno	NULL
,	NULL
and	NULL
C.	NULL
V.	NULL
Jongeneel	NULL
.	NULL

1999	NULL
.	NULL

Efficient	NULL
adenoviral	NULL
transfer	NULL
of	NULL
NF-KB	NULL
inhibitor	NULL
sensitises	NULL
melanoma	NULL
to	NULL
tumour	NULL
necrosis	NULL
factor-me-diated	NULL
apoptosis	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
80:320	NULL
.	NULL

Becker	NULL
,	NULL
T.	NULL
C.	NULL
,	NULL
R.	NULL
J.	NULL
Noel	NULL
,	NULL
W.	NULL
S.	NULL
Coats	NULL
,	NULL
A.	NULL
M.	NULL
Gomez-Foix	NULL
,	NULL
T.	NULL
Alam	NULL
,	NULL
R.	NULL
D.	NULL
Gerard	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Newgard	NULL
.	NULL

1994	NULL
.	NULL

Use	NULL
of	NULL
recombinant	NULL
adenovirus	NULL
for	NULL
metabolic	NULL
engineering	NULL
of	NULL
mammalian	NULL
cells	NULL
.	NULL

Methods	NULL
Cell	NULL
Biol	NULL
.	NULL

43:161	NULL
.	NULL

Jenkinson	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
Owen	NULL
.	NULL

1990	NULL
.	NULL

T-cell	NULL
differentiation	NULL
in	NULL
thymus	NULL
organ	NULL
cultures	NULL
.	NULL

Semin	NULL
.	NULL

Immunol	NULL
.	NULL

2:51	NULL
.	NULL

Lesley	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
I.	NULL
S.	NULL
Trowbridge	NULL
.	NULL

1982	NULL
.	NULL

Genetic	NULL
characterization	NULL
of	NULL
a	NULL
polymorphic	NULL
murine	NULL
cell-surface	NULL
glycoprotein	NULL
.	NULL

Immunogenetics	NULL
15:313	NULL
.	NULL

Pierres	NULL
,	NULL
M.	NULL
,	NULL
C.	NULL
Goridis	NULL
,	NULL
and	NULL
P.	NULL
Golstein	NULL
.	NULL

1982	NULL
.	NULL

Inhibition	NULL
of	NULL
murine	NULL
T	NULL
cell-me-diated	NULL
cytolysis	NULL
and	NULL
T	NULL
cell	NULL
proliferation	NULL
by	NULL
a	NULL
rat	NULL
monoclonal	NULL
antibody	NULL
immuno-precipitating	NULL
two	NULL
lymphoid	NULL
cell	NULL
surface	NULL
polypeptides	NULL
of	NULL
94	NULL
000	NULL
and	NULL
180,000	NULL
molecular	NULL
weight	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

12:60	NULL
.	NULL

Renno	NULL
,	NULL
T.	NULL
,	NULL
M.	NULL
Hahne	NULL
,	NULL
J.	NULL
Tschopp	NULL
,	NULL
and	NULL
H.	NULL
R.	NULL
MacDonald	NULL
.	NULL

1996	NULL
.	NULL

Peripheral	NULL
T	NULL
cells	NULL
undergoing	NULL
superantigen-induced	NULL
apoptosis	NULL
in	NULL
vivo	NULL
express	NULL
B220	NULL
and	NULL
upregulate	NULL
Fas	NULL
and	NULL
Fas	NULL
ligand	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

183:431	NULL
.	NULL

Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
S.	NULL
Fiering	NULL
,	NULL
J.	NULL
F.	NULL
Nicolas	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Herzenberg	NULL
.	NULL

1988	NULL
.	NULL

Fluorescence-activated	NULL
cell	NULL
analysis	NULL
and	NULL
sorting	NULL
of	NULL
viable	NULL
mammalian	NULL
cells	NULL
based	NULL
on	NULL
galactosidase	NULL
activity	NULL
after	NULL
transduction	NULL
of	NULL
Escherichia	NULL
coli	NULL
lacZ	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:2603	NULL
.	NULL

Albrecht	NULL
,	NULL
H.	NULL
,	NULL
J.	NULL
Tschopp	NULL
,	NULL
and	NULL
C.	NULL
V.	NULL
Jongeneel	NULL
.	NULL

1994	NULL
.	NULL

Bel-2	NULL
protects	NULL
from	NULL
oxi-dative	NULL
damage	NULL
and	NULL
apoptotic	NULL
cell	NULL
death	NULL
without	NULL
interfering	NULL
with	NULL
activation	NULL
of	NULL
NF-B	NULL
by	NULL
TNF	NULL
.	NULL

FEBS	NULL
Lett	NULL
.	NULL

351:45	NULL
.	NULL

Moore	NULL
,	NULL
N.	NULL
C.	NULL
,	NULL
J.	NULL
Girdlestone	NULL
,	NULL
G.	NULL
Anderson	NULL
,	NULL
J.	NULL
J.	NULL
Owen	NULL
,	NULL
and	NULL
E.	NULL
J.	NULL
Jenkinson	NULL
.	NULL

1995	NULL
.	NULL

Stimulation	NULL
of	NULL
thymocytes	NULL
before	NULL
and	NULL
after	NULL
positive	NULL
selection	NULL
results	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
different	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

protein	NULL
complexes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

155:4653	NULL
.	NULL

Shinkai	NULL
,	NULL
Y.	NULL
,	NULL
S.	NULL
Koyasu	NULL
,	NULL
K.	NULL
Nakayama	NULL
,	NULL
K.	NULL
M.	NULL
Murphy	NULL
,	NULL
D.	NULL
Y.	NULL
Loh	NULL
,	NULL
E.	NULL
L.	NULL
Reinherz	NULL
,	NULL
and	NULL
F.	NULL
W.	NULL
Alt	NULL
.	NULL

1993	NULL
.	NULL

Restoration	NULL
of	NULL
T	NULL
cell	NULL
development	NULL
in	NULL
RAG-2-deficient	NULL
mice	NULL
by	NULL
functional	NULL
TCR	NULL
transgenes	NULL
.	NULL

Science	NULL
259:822	NULL
.	NULL

Schuler	NULL
,	NULL
W.	NULL
,	NULL
I.	NULL
J.	NULL
Weiler	NULL
,	NULL
A.	NULL
Schuler	NULL
,	NULL
R.	NULL
A.	NULL
Phillips	NULL
,	NULL
N.	NULL
Rosenberg	NULL
,	NULL
T.	NULL
W.	NULL
Mak	NULL
,	NULL
J.	NULL
F.	NULL
Kearney	NULL
,	NULL
R.	NULL
P.	NULL
Perry	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Bosma	NULL
.	NULL

1986	NULL
.	NULL

Rearrangement	NULL
of	NULL
antigen	NULL
33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

NEF-	NULL
«	NULL
B	NULL
IN	NULL
FETAL	NULL
THYMOCYTE	NULL
DEVELOPMENT	NULL
receptor	NULL
genes	NULL
is	NULL
defective	NULL
in	NULL
mice	NULL
with	NULL
severe	NULL
combined	NULL
immune	NULL
deficiency	NULL
.	NULL

Cell	NULL
46:963	NULL
.	NULL

Mombaerts	NULL
,	NULL
P.	NULL
,	NULL
A.	NULL
R.	NULL
Clarke	NULL
,	NULL
M.	NULL
A.	NULL
Rudnicki	NULL
,	NULL
J.	NULL
Iacomini	NULL
,	NULL
S.	NULL
Itohara	NULL
,	NULL
J.	NULL
J.	NULL
Lafaille	NULL
,	NULL
L.	NULL
Wang	NULL
,	NULL
Y.	NULL
Ichikawa	NULL
,	NULL
R.	NULL
Jaenisch	NULL
,	NULL
M.	NULL
L.	NULL
Hooper	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1992	NULL
.	NULL

Mutations	NULL
in	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
genes	NULL
a	NULL
and	NULL
B	NULL
block	NULL
thymocyte	NULL
development	NULL
at	NULL
different	NULL
stages	NULL
.	NULL

Nature	NULL
360:225	NULL
.	NULL

Mombaerts	NULL
,	NULL
P.	NULL
,	NULL
J.	NULL
Iacomini	NULL
,	NULL
R.	NULL
S.	NULL
Johnson	NULL
,	NULL
K.	NULL
Herrup	NULL
,	NULL
S.	NULL
Tonegawa	NULL
,	NULL
and	NULL
V.	NULL
E.	NULL
Papaioannou	NULL
.	NULL

1992	NULL
.	NULL

RAG-1-deficient	NULL
mice	NULL
have	NULL
no	NULL
mature	NULL
B	NULL
and	NULL
T	NULL
lym-phocytes	NULL
.	NULL

Cell	NULL
68:869	NULL
.	NULL

Van	NULL
Antwerp	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
S.	NULL
J.	NULL
Martin	NULL
,	NULL
T.	NULL
Kafri	NULL
,	NULL
D.	NULL
R.	NULL
Green	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1996	NULL
.	NULL

Suppression	NULL
of	NULL
TNFa-induced	NULL
apoptosis	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Science	NULL
274:787	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1996	NULL
.	NULL

An	NULL
essential	NULL
role	NULL
for	NULL
NF-B	NULL
in	NULL
preventing	NULL
TNFa-induced	NULL
cell	NULL
death	NULL
.	NULL

Science	NULL
274:782	NULL
.	NULL

Kishimoto	NULL
,	NULL
H.	NULL
,	NULL
C.	NULL
D.	NULL
Surh	NULL
,	NULL
and	NULL
J.	NULL
Sprent	NULL
.	NULL

1995	NULL
.	NULL

Upregulation	NULL
of	NULL
surface	NULL
markers	NULL
on	NULL
dying	NULL
thymocytes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181:649	NULL
.	NULL

Fehling	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
and	NULL
H.	NULL
Vonboehmer	NULL
.	NULL

1997	NULL
.	NULL

Early	NULL
«	NULL
B	NULL
T	NULL
cell	NULL
development	NULL
in	NULL
the	NULL
thymus	NULL
of	NULL
normal	NULL
and	NULL
genetically	NULL
altered	NULL
mice	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

9:263	NULL
.	NULL

DeMatteo	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
S.	NULL
E.	NULL
Raper	NULL
,	NULL
M.	NULL
Abn	NULL
,	NULL
K.	NULL
J.	NULL
Fisher	NULL
,	NULL
C.	NULL
Burke	NULL
,	NULL
A.	NULL
Radu	NULL
,	NULL
G.	NULL
Widera	NULL
,	NULL
B.	NULL
R.	NULL
Claytor	NULL
,	NULL
C.	NULL
F.	NULL
Barker	NULL
,	NULL
and	NULL
J.	NULL
F.	NULL
Markmann	NULL
.	NULL

1995	NULL
.	NULL

Gene	NULL
transfer	NULL
to	NULL
the	NULL
thymus	NULL
:	NULL
a	NULL
means	NULL
of	NULL
abrogating	NULL
the	NULL
immune	NULL
response	NULL
to	NULL
recombinant	NULL
ad-enovirus	NULL
.	NULL

Ann	NULL
.	NULL

Surg	NULL
.	NULL

222:229	NULL
.	NULL

Staal	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
P.	NULL
C.	NULL
Res	NULL
,	NULL
K.	NULL
Weijer	NULL
,	NULL
and	NULL
H.	NULL
Spits	NULL
.	NULL

1995	NULL
.	NULL

Development	NULL
of	NULL
retrovirally	NULL
marked	NULL
human	NULL
T	NULL
progenitor	NULL
cells	NULL
into	NULL
mature	NULL
thymocytes	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

7:1301	NULL
.	NULL

Crompton	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
C.	NULL
Gilmour	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Owen	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
MAP	NULL
kinase	NULL
pathway	NULL
controls	NULL
differentiation	NULL
from	NULL
double-negative	NULL
to	NULL
double-positive	NULL
thymocyte	NULL
.	NULL

Cell	NULL
86:243	NULL
.	NULL

Levelt	NULL
,	NULL
C.	NULL
N.	NULL
,	NULL
R.	NULL
Carsetti	NULL
,	NULL
and	NULL
K.	NULL
Eichmann	NULL
.	NULL

1993	NULL
.	NULL

Regulation	NULL
of	NULL
thymocyte	NULL
development	NULL
through	NULL
CD3	NULL
.	NULL

II	NULL
.	NULL

Expression	NULL
of	NULL
T	NULL
cell	NULL
receptor	NULL
B	NULL
CD3	NULL
epsilon	NULL
and	NULL
maturation	NULL
to	NULL
the	NULL
CD4*8*	NULL
stage	NULL
are	NULL
highly	NULL
correlated	NULL
in	NULL
individual	NULL
thymocytes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:1867	NULL
.	NULL

Jacobs	NULL
,	NULL
H.	NULL
,	NULL
D.	NULL
Vandeputte	NULL
,	NULL
L.	NULL
Tolkamp	NULL
,	NULL
E.	NULL
de	NULL
Vries	NULL
,	NULL
J.	NULL
Borst	NULL
,	NULL
and	NULL
A.	NULL
Berns	NULL
.	NULL

1994	NULL
.	NULL

CD3	NULL
components	NULL
at	NULL
the	NULL
surface	NULL
of	NULL
pro-T	NULL
cells	NULL
can	NULL
mediate	NULL
pre-T	NULL
cell	NULL
development	NULL
in	NULL
vivo	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

24:934	NULL
.	NULL

Wu	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Lee	NULL
,	NULL
R.	NULL
E.	NULL
Bellas	NULL
,	NULL
S.	NULL
L.	NULL
Schauer	NULL
,	NULL
M.	NULL
Arsura	NULL
,	NULL
D.	NULL
Katz	NULL
,	NULL
M.	NULL
J.	NULL
FitzGerald	NULL
,	NULL
T.	NULL
L.	NULL
Rothstein	NULL
,	NULL
D.	NULL
H.	NULL
Sherr	NULL
,	NULL
and	NULL
G.	NULL
E.	NULL
Sonenshein	NULL
.	NULL

1996	NULL
.	NULL

Inhibition	NULL
of	NULL
Rel	NULL
induces	NULL
apoptosis	NULL
of	NULL
murine	NULL
B	NULL
cells	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:4682	NULL
.	NULL

Horwitz	NULL
,	NULL
B.	NULL
H.	NULL
,	NULL
M.	NULL
L.	NULL
Scott	NULL
,	NULL
S.	NULL
R.	NULL
Cherry	NULL
,	NULL
R.	NULL
T.	NULL
Bronson	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1997	NULL
.	NULL

Failure	NULL
of	NULL
lymphopoiesis	NULL
after	NULL
adoptive	NULL
transfer	NULL
of	NULL
NE-B-deficient	NULL
fetal	NULL
liver	NULL
cells	NULL
.	NULL

Immunity	NULL
6:765	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
T.	NULL
Henkel	NULL
.	NULL

1994	NULL
.	NULL

Function	NULL
and	NULL
activation	NULL
of	NULL
NF-KB	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Anru	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:141	NULL
.	NULL

Kelner	NULL
,	NULL
G.	NULL
S.	NULL
,	NULL
and	NULL
A.	NULL
Zlotnik	NULL
.	NULL

1995	NULL
.	NULL

Cytokine	NULL
production	NULL
profile	NULL
of	NULL
early	NULL
thymocytes	NULL
and	NULL
the	NULL
characterization	NULL
of	NULL
a	NULL
new	NULL
class	NULL
of	NULL
chemokine	NULL
.	NULL

J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

57:778	NULL
.	NULL

Moore	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
A.	NULL
Zlotnik	NULL
.	NULL

1995	NULL
.	NULL

T-cell	NULL
lincage	NULL
commitment	NULL
and	NULL
cytokine	NULL
responses	NULL
of	NULL
thymic	NULL
progenitors	NULL
.	NULL

Blood	NULL
86:1850	NULL
.	NULL

Kroemer	NULL
,	NULL
G.	NULL
1997	NULL
.	NULL

The	NULL
proto-oncogene	NULL
Bcl-2	NULL
and	NULL
its	NULL
role	NULL
in	NULL
regulating	NULL
apoptosis	NULL
.	NULL

Nat	NULL
.	NULL

Med	NULL
.	NULL

3:614	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL

